Replacement heart valve implant with invertible leaflets

Description

TECHNICAL FIELD

The present disclosure pertains to medical devices, and methods for manufacturing and/or using medical devices. More particularly, the present disclosure pertains to configurations of a replacement heart valve.

BACKGROUND

A wide variety of intracorporeal medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires, catheters, medical device delivery systems (e.g., for stents, grafts, replacement valves, etc.), and the like. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.

SUMMARY

In a first aspect, a locking mechanism for a medical implant may comprise a buckle member, a post member axially translatable with respect to the buckle member, the post member including a receiving portion proximate a proximal end of the post member, a distal end, a laterally-arched central body portion extending between the receiving portion and the distal end, and a cantilevered leg extending proximally from the distal end, and an actuator element including a proximal shaft portion and a distal engagement portion, the distal engagement portion being configured to releasably engage the receiving portion of the post member. The proximal shaft portion may be pivotable with respect to the distal engagement portion.

In addition or alternatively, and in a second aspect, the actuator element includes a hinge element disposed between the proximal shaft portion and the distal engagement portion.

In addition or alternatively, and in a third aspect, the post member includes at least one aperture extending therethrough proximate the distal end, the at least one aperture being configured to receive a coupling element therethrough.

In addition or alternatively, and in a fourth aspect, the distal engagement portion includes a lateral protrusion proximate a distal end of the distal engagement portion.

In addition or alternatively, and in a fifth aspect, the lateral protrusion is configured to engage with an aperture disposed within the receiving portion.

In addition or alternatively, and in a sixth aspect, the laterally-arched central body portion includes a tooth extending laterally therefrom.

In addition or alternatively, and in a seventh aspect, the tooth extends toward the cantilevered leg.

In addition or alternatively, and in an eighth aspect, the central body portion arches laterally in a first direction relative to the proximal end and the distal end, and the tooth extends laterally in the first direction from the central body portion.

In addition or alternatively, and in a ninth aspect, the cantilevered leg includes a longitudinally-oriented slot extending therethrough.

In addition or alternatively, and in a tenth aspect, the receiving portion includes a first portion and a second portion configured to splay apart as the post member is translated proximally within the buckle member to release the distal engagement portion therefrom.

In addition or alternatively, and in an eleventh aspect, the buckle member is formed of a substantially rigid material.

In addition or alternatively, and in a twelfth aspect, the central body portion is configured to flex towards a substantially straight configuration upon proximal translation through the buckle member.

In addition or alternatively, and in a thirteenth aspect, a replacement heart valve implant may comprise a tubular anchor member defining a central longitudinal axis; a plurality of locking mechanisms, each locking mechanism comprising a buckle member fixedly attached to the tubular anchor member, and a post member axially translatable with respect to the buckle member, the post member including a receiving portion proximate a proximal end of the post member, a distal end, a laterally-arched central body portion extending between the receiving portion and the distal end, and a cantilevered leg extending proximally from the distal end; a plurality of valve leaflets, wherein each valve leaflet is coupled to the cantilevered leg of at least one of the plurality of locking mechanisms; and a plurality of actuator elements corresponding to the plurality of locking mechanisms, each actuator element including a proximal shaft portion and a distal engagement portion, wherein the proximal shaft portion is pivotable relative to the distal engagement portion, wherein the distal engagement portion is releasably fixed to the receiving portion of one post member.

In addition or alternatively, and in a fourteenth aspect, the buckle member of each locking mechanism is positioned against an inner surface of the tubular anchor member.

In addition or alternatively, and in a fifteenth aspect, the plurality of valve leaflets is configured to shift between an everted position wherein a free end of each of the plurality of valve leaflets is disposed distally of the tubular anchor member, and a deployed position wherein the free end of each of the plurality of valve leaflets is disposed within the tubular anchor member.

In addition or alternatively, and in a sixteenth aspect, in the everted position, each of the plurality of actuator elements extends distally of the tubular anchor member.

In addition or alternatively, and in a seventeenth aspect, each of the plurality of valve leaflets is secured to the tubular anchor member at a secured end opposite the free end.

In addition or alternatively, and in an eighteenth aspect, a replacement heart valve implant may comprise a tubular anchor member defining a central longitudinal axis, the tubular anchor member being configured to shift between a delivery configuration and a deployed configuration; a plurality of locking mechanisms, each locking mechanism comprising a buckle member fixedly attached to the tubular anchor member, and a post member axially translatable with respect to the buckle member, the post member including a receiving portion proximate a proximal end of the post member, a distal end, a laterally-arched central body portion extending from the receiving portion to the distal end, and a cantilevered leg extending proximally from the distal end; a plurality of valve leaflets, wherein each valve leaflet is coupled to the cantilevered leg of at least one of the plurality of locking mechanisms; and a plurality of actuator elements corresponding to the plurality of locking mechanisms, each actuator element including a proximal shaft portion pivotably connected to a distal engagement portion, the distal engagement portion being releasably fixed to the receiving portion of one post member, wherein the distal engagement portion is configured to pivot with respect to the proximal shaft portion in a radial direction relative to the central longitudinal axis.

In addition or alternatively, and in a nineteenth aspect, each actuator element extends through the buckle member of its corresponding locking mechanism when the tubular anchor member is in the delivery configuration, and each actuator element is configured to translate the post member of its corresponding locking mechanism into engagement with the buckle member of its corresponding locking mechanism upon proximal retraction of the plurality of actuator elements.

In addition or alternatively, and in a twentieth aspect, the post member is at least partially disposed distally of the tubular anchor member when the tubular anchor member is in the delivery configuration, and the post member is locked within the buckle member when the tubular anchor member is in the deployed configuration.

The above summary of some embodiments, aspects, and/or examples is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.

BRIEF DESCRIPTION OF THE DRAWINGS

The disclosure may be more completely understood in consideration of the following detailed description of various embodiments in connection with the accompanying drawings, in which:

FIG. 1 illustrates an example medical implant system;

FIG. 2 illustrates an example medical implant in a deployed configuration;

FIG. 3 is an isometric view of an example buckle member associated with an example medical implant;

FIG. 4 is an isometric view of an example post member associated with an example medical implant;

FIG. 5 is an isometric view of an example actuator member associated with an example medical implant system;

FIG. 6 illustrates selected portions of an example medical implant in a delivery or everted configuration;

FIG. 7 illustrates selected portions of an example medical implant in a partially deployed configuration;

FIG. 8 illustrates selected portions of an example medical implant in a partially deployed configuration;

FIG. 9 illustrates selected components of an example medical implant associated with an example medical implant system in a partially deployed configuration;

FIG. 10 illustrates selected components of an example medical implant associated with an example medical implant system in a deployed configuration;

FIGS. 11-12 illustrate selected components of an example medical implant associated with an example medical implant system in a partially-released configuration; and

FIG. 13 illustrates selected components of an example medical implant associated with an example medical implant system in a released configuration.

While aspects of the disclosure are amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit aspects of the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.

DETAILED DESCRIPTION

The following description should be read with reference to the drawings, which are not necessarily to scale, wherein like reference numerals indicate like elements throughout the several views. The detailed description and drawings are intended to illustrate but not limit the claimed invention. Those skilled in the art will recognize that the various elements described and/or shown may be arranged in various combinations and configurations without departing from the scope of the disclosure. The detailed description and drawings illustrate example embodiments of the claimed invention.

For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.

All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about”, in the context of numeric values, generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (e.g., having the same function or result). In many instances, the term “about” may include numbers that are rounded to the nearest significant figure. Other uses of the term “about” (e.g., in a context other than numeric values) may be assumed to have their ordinary and customary definition(s), as understood from and consistent with the context of the specification, unless otherwise specified.

The recitation of numerical ranges by endpoints includes all numbers within that range, including the endpoints (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).

Although some suitable dimensions, ranges, and/or values pertaining to various components, features and/or specifications are disclosed, one of skill in the art, incited by the present disclosure, would understand desired dimensions, ranges, and/or values may deviate from those expressly disclosed.

As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.

Relative terms such as “proximal”, “distal”, “advance”, “retract”, variants thereof, and the like, may be generally be considered with respect to the positioning, direction, and/or operation of various elements relative to a user/operator/manipulator of the device, wherein “proximal” and “retract” indicate or refer to closer to or toward the user and “distal” and “advance” indicate or refer to farther from or away from the user. Other relative terms, such as “upstream”, “downstream”, “inflow”, and “outflow” refer to a direction of fluid flow within a lumen, such as a body lumen, a blood vessel, or within a device.

It is noted that references in the specification to “an embodiment”, “some embodiments”, “other embodiments”, etc., indicate that the embodiment(s) described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an embodiment, it would be within the knowledge of one skilled in the art to effect such feature, structure, or characteristic in connection with other embodiments, whether or not explicitly described, unless clearly stated to the contrary. That is, the various individual elements described below, even if not explicitly shown in a particular combination, are nevertheless contemplated as being combinable or arrangable with each other to form other additional embodiments or to complement and/or enrich the described embodiment(s), as would be understood by one of ordinary skill in the art.

For the purpose of clarity, certain identifying numerical nomenclature (e.g., first, second, third, fourth, etc.) may be used throughout the description and/or claims to name and/or differentiate between various described and/or claimed features. It is to be understood that the numerical nomenclature is not intended to be limiting and is exemplary only. In some embodiments, alterations of and deviations from previously-used numerical nomenclature may be made in the interest of brevity and clarity. That is, a feature identified as a “first” element may later be referred to as a “second” element, a “third” element, etc. or may be omitted entirely, and/or a different feature may be referred to as the “first” element. The meaning and/or designation in each instance will be apparent to the skilled practitioner.

Diseases and/or medical conditions that impact the cardiovascular system are prevalent in the United States and throughout the world. Traditionally, treatment of the cardiovascular system was often conducted by directly accessing the impacted part of the system. For example, treatment of a blockage in one or more of the coronary arteries was traditionally treated using coronary artery bypass surgery. As can be readily appreciated, such therapies are rather invasive to the patient and require significant recovery times and/or treatments. More recently, less invasive therapies have been developed, for example, where a blocked coronary artery could be accessed and treated via a percutaneous catheter (e.g., angioplasty). Such therapies have gained wide acceptance among patients and clinicians.

Some relatively common medical conditions may include or be the result of inefficiency, ineffectiveness, or complete failure of one or more of the valves within the heart. For example, failure of the aortic valve or the mitral valve can have a serious effect on a human and could lead to serious health condition and/or death if not dealt with. Treatment of defective heart valves poses other challenges in that the treatment often requires the repair or outright replacement of the defective valve. Such therapies may be highly invasive to the patient. Disclosed herein are medical devices that may be used for delivering a medical device to a portion of the cardiovascular system in order to diagnose, treat, and/or repair the system. At least some of the medical devices disclosed herein may be used to deliver and implant a replacement heart valve (e.g., a replacement aortic valve, replacement mitral valve, etc.). In addition, the devices disclosed herein may deliver the replacement heart valve percutaneously and, thus, may be much less invasive to the patient. The devices disclosed herein may also provide a number of additional desirable features and benefits as described in more detail below.

The figures illustrate selected components and/or arrangements of a medical implant system 10, shown schematically in FIG. 1 for example. It should be noted that in any given figure, some features of the medical implant system 10 may not be shown, or may be shown schematically, for simplicity. Additional details regarding some of the components of the medical implant system 10 may be illustrated in other figures in greater detail. A medical implant system 10 may be used to deliver and/or deploy a variety of medical devices to a number of locations within the anatomy. In at least some embodiments, the medical implant system 10 may include a replacement heart valve delivery system (e.g., a replacement aortic valve delivery system) that can be used for percutaneous delivery of a medical implant 14, such as a replacement heart valve. This, however, is not intended to be limiting as the medical implant system 10 may also be used for other interventions including valve repair, valvuloplasty, and the like, or other similar interventions.

The medical implant system 10, as seen in FIG. 1 for example, may generally be described as a catheter system that includes a delivery system 12 and the medical implant 14 (e.g., a replacement heart valve implant, for example, which term may be used interchangeably with the term “medical implant” herein) which may be coupled to the delivery system 12 and disposed within a lumen of the delivery system 12 during delivery of the medical implant 14. In some embodiments, a handle 18 may be disposed and/or attached at a proximal end of the delivery system 12, as seen in FIG. 1, and may include at least one actuation means associated therewith. In some embodiments, the handle 18 may be configured to manipulate the position of the delivery system 12 and/or aid in the deployment of the medical implant 14. In some embodiments, the medical implant system 10 may include a nose cone disposed at a distal end of a guidewire extension tube, wherein the guidewire extension tube may extend distally from the delivery system 12. In at least some embodiments, the nose cone may be designed to have an atraumatic shape. In some embodiments, the nose cone may include a ridge or ledge that is configured to abut a distal tip of the delivery system 12 during delivery of the medical implant 14.

In use, the medical implant system 10 may be advanced percutaneously through the vasculature to a position proximate to an area of interest and/or a treatment location. For example, in some embodiments, the medical implant system 10 may be advanced through the vasculature to a position proximate to a defective native valve (e.g., aortic valve, mitral valve, etc.). Alternative approaches to treat a defective aortic valve and/or other heart valve(s) are also contemplated with the medical implant system 10. During delivery, the medical implant 14 may be generally disposed in an elongated and low profile “delivery” configuration within the delivery system 12. Once positioned, at least a portion of the delivery system 12 may be retracted relative to the medical implant 14 to expose the medical implant 14. In some embodiments, the medical implant 14 may be disposed in an “everted” configuration while disposed within the lumen and/or the distal end of the delivery system 12 and/or immediately upon exposure after retracting the delivery system 12. In some embodiments, the “delivery” configuration and the “everted” configuration may be substantially similar and/or may be used interchangeably. The medical implant 14 may be actuated using the handle 18 in order to translate the medical implant 14 into a generally shortened and larger profile “deployed” configuration suitable for implantation within the anatomy, as seen in FIG. 2 for example. When the medical implant 14 is suitably deployed within the anatomy, the medical implant 14 may be released and/or detached from the medical implant system 10 and the delivery system 12 can be removed from the vasculature, thereby leaving the medical implant 14 in place in a “released” configuration, to function as, for example, a suitable replacement for the native valve. In at least some interventions, the medical implant 14 may be deployed within the native valve (e.g., the native valve is left in place and not excised). Alternatively, the native valve may be removed and the medical implant 14 may be deployed in its place as a replacement.

In some embodiments, the delivery system 12 may include at least one lumen extending therethrough. For example, in some embodiments, the delivery system 12 may include a first lumen, a second lumen, a third lumen, and a fourth lumen. Other configurations are also contemplated. In general, the at least one lumen extend along an entire length of the delivery system 12. Other embodiments are contemplated, however, where at least one of the at least one lumen extends along only a portion of the length of the delivery system 12. In some embodiments, a coupler assembly 32 may be attached at and/or to a distal end of the delivery system 12. In some embodiments, the coupler assembly 32 may releasably couple the medical implant 14 and/or selected components thereof to the delivery system 12. In some embodiments, the coupler assembly 32 may include a plurality of fingers, as discussed in more detail below.

In some embodiments, disposed within one of the lumens of the delivery system 12 may be at least one actuator member 50, which may be used to actuate (e.g., translate axially or longitudinally, and/or expand) the medical implant 14 between a delivery configuration and a deployed configuration. In some embodiments, the medical implant system 10 may include at least one actuator member 50. In some embodiments, the at least one actuator member 50 may include a plurality of actuator members 50, two actuator members 50, three actuator members 50, four actuator members 50, or another suitable or desired number of actuator members 50. For the purpose of illustration only, the medical implant system 10 and/or the medical implant 14 of FIG. 2 is configured to use three actuator members 50. In use, a proximal end of an actuator member 50 may be connected to the handle 18, and/or manipulated or otherwise actuated by a user using the handle 18, to shift the tubular anchor member 40 and/or the medical implant 14 from a “delivery” configuration to a “deployed” configuration, and later to a “released” configuration. During the release process for the medical implant 14, (e.g., as the medical implant 14 and/or the tubular anchor member 40 is actuated from the “delivery” configuration to the “deployed” configuration to the “released” configuration), the at least one actuator member 50 may be retracted, withdrawn, and/or translated proximally relative to delivery system 12, the medical implant 14, and/or components or elements thereof.

It is to be noted that in order to facilitate understanding, certain features of the disclosure may be described in the singular, even though those features may be plural or recurring within the disclosed embodiment(s). Each instance of the features may include and/or be encompassed by the singular disclosure(s), unless expressly stated to the contrary. For example, a reference to “the actuator member”, “the locking element”, “the lumen”, or other features may be equally referred to all instances and quantities beyond one of said feature. As such, it will be understood that the following discussion may apply equally to any and/or all of the components for which there are more than one within the medical implant 14 (e.g., the at least one actuator member 50, the plurality of locking elements, etc.) and/or the medical implant system 10, unless explicitly stated to the contrary. Additionally, not all instances of some elements or features may be shown in each figure for clarity.

FIG. 2 illustrates some selected components of the medical implant system 10 and/or the medical implant 14 in the “deployed” configuration. For example, the medical implant 14 includes a plurality of valve leaflets 16 (e.g., bovine pericardial, polymeric, etc.) which may be secured to a tubular anchor member 40 that is actuatable between an elongated “delivery” configuration, as in FIG. 1 for example, and an expanded “deployed” configuration, as in FIG. 2. In some embodiments, the tubular anchor member 40 may include a proximal end and a distal end. In some embodiments, the tubular anchor member 40 may form a tubular structure defining a central longitudinal axis extending from the proximal end of the tubular anchor member 40 to the distal end of the tubular anchor member 40, and/or a lumen extending through the tubular anchor member 40 along, parallel to, coaxial with, and/or coincident with the central longitudinal axis. In some embodiments, the tubular anchor member 40 may be and/or include a braid formed from at least one filament or wire (e.g., a single filament or wire, two filaments or wires, etc.). Other configurations are also contemplated. Some suitable but non-limiting materials for the tubular anchor member 40, for example metallic materials or polymeric materials, are described below.

In some embodiments, the tubular anchor member 40 may include and/or form a plurality of anchor member intersection points 42 distributed around a circumference of the tubular anchor member 40. In some embodiments, the plurality of anchor member intersection points 42 may include two or more overlapping segments (e.g., a first segment, a second segment, a third segment, etc.) of the tubular anchor member 40 and/or the braid, filaments, wires, etc. thereof. In some embodiments, the two or more overlapping segments may be arranged in an alternating over-and-under pattern or arrangement. For example, at a first anchor member intersection point 42, a first segment may be disposed radially outward of a second segment. At an adjacent second anchor member intersection point 42 including the first segment, the first segment may be disposed radially inward of an overlapping segment (e.g., a third segment). If the first segment (or any single segment) is followed around the circumference of the tubular anchor member 40, the over-under-over pattern would continue alternating about the entire circumference of the tubular anchor member 40.

In some embodiments, the medical implant 14 may include a plurality of locking mechanisms attached to the tubular anchor member 40, the plurality of locking mechanisms being configured to secure the tubular anchor member 40 in the “deployed” and/or “released” configuration(s). In some embodiments, the medical implant 14 and/or the tubular anchor member 40 may be reversed and/or longitudinally extended back toward the “delivery” configuration at any point up until the plurality of locking mechanisms actually “locks” the medical implant 14 and/or the tubular anchor member in the “deployed” configuration. In some embodiments, the at least one actuator member 50 may be configured to engage with the plurality of locking mechanisms and actuate the tubular anchor member 40 and/or the medical implant 14 between the “delivery” configuration, the “deployed” configuration, and/or the “released” configuration. In some embodiments, one actuator member 50 may correspond to, engage with, and/or actuate one locking mechanism. In some embodiments, each actuator member 50 may extend through a guide 38 adjacent to and covering one of the plurality of fingers, as described herein, of the coupler assembly 32, and through a collar 36 coupling and/or locking the finger to one of the plurality of locking mechanisms. The guide 38 may be disposed over each of the fingers proximal of the collar 36 and may serve to keep the fingers of the coupler assembly 32 associated with the actuator members 50 extending adjacent to (and axially slidable relative to) the fingers of the coupler assembly 32. Other configurations are also contemplated. For example, in some embodiments, one actuator member 50 may correspond to, engage with, and/or actuate more than one locking mechanism.

For simplicity and clarity purposes, not all elements of the disclosed invention are necessarily shown in each figure. In some illustrative examples, only one of the fingers of the coupler assembly 32, only one of the plurality of actuator members 50, only one of the post members 76, only one of the buckle members 58, only one of the collars 36, etc. are shown and discussed (the whole medical implant 14 and/or the tubular anchor member 40 may not be shown to facilitate understanding of the locking mechanisms and/or other elements). However, it will be understood that the following discussion may apply equally to any and/or all of the components for which there are more than one within the medical implant 14 (e.g., each of the plurality of fingers 34, collars 36, guides 38, actuator members 50, buckle members 58, post members 76, etc.) and/or the medical implant system 10.

In some embodiments, the plurality of locking mechanisms may each comprise a buckle member 58 or other receiving element fixedly attached to the tubular anchor member 40 (e.g., along an inner surface of the tubular anchor member 40), and an axially movable post member 76, for example at the commissure portions of the valve leaflets 16 (a post member 76 may sometimes be referred to as a “commissure post”, which may serve to secure the plurality of valve leaflets 16, or a post member 76 may be connected and/or attached to a commissure post). In some embodiments, the buckle member 58 or other receiving element may be configured to slidably receive at least a portion of the post member 76 therein to engage with the buckle member 58 and thereafter lock the tubular anchor member 40 and/or the medical implant 14 in the “deployed” and/or the “released” configuration(s). In some embodiments, each of the plurality of valve leaflets 16 may be secured to the tubular anchor member 40 at one post member 76. In some embodiments, each of the plurality of valve leaflets 16 may be secured to two adjacent post members 76 at opposing sides of the valve leaflet 16. In at least some embodiments, a medical implant 14 may include a plurality of post members 76 and a corresponding plurality of buckle members 58 (e.g., one post member 76 for each/one buckle member 58). Other configurations and correspondences are also contemplated. Some suitable but non-limiting materials for the buckle member(s) 58 and/or the post member(s) 76, for example metallic materials or polymeric materials, may be described below.

Positioned proximate to (e.g., aligned with) the plurality of post members 76 may be a corresponding plurality of buckle members 58, which may be secured and/or fixedly attached to the tubular anchor member 40 (e.g., along the interior of the tubular anchor member 40) with sutures, adhesives, or other suitable mechanisms. In some embodiments, the post member 76 may be axially translatable relative to the buckle member 58 generally parallel to the central longitudinal axis of the tubular anchor member 40 when the post member 76 is at least partially disposed within and/or engaged with the buckle member 58.

In some embodiments, one buckle member 58 may be fixedly attached to the tubular anchor member 40 proximate to each of the three post members 76 and/or proximate the proximal end of the tubular anchor member 40. Accordingly, in some embodiments, the tubular anchor member 40 may have a total of three buckle members 58 and three post members 76 attached thereto. Similarly, one actuator member 50 may be associated with each post member 76 and buckle member 58, for a total of three actuator members 50 in the illustrated example(s). Other embodiments are contemplated where fewer or more buckle members 58, post members 76, and/or actuator members 50 may be utilized.

In some embodiments, the medical implant 14 and/or the tubular anchor member may be attached, coupled, and/or connected to the delivery system 12 by a coupler assembly 32, as seen in FIG. 2 for example. The coupler assembly 32 may generally include a cylindrical base (not shown) that may be attached to and/or extending from a distal end of the delivery system 12 and/or a portion or component thereof. Projecting distally from the base is a plurality of fingers (e.g., two fingers, three fingers, four fingers, etc.) that are each configured to engage with the medical implant 14 at the buckle members 58 (for example, at a proximal end of the buckle members 58), with the plurality of actuator members 50 extending therethrough and engaging the post members 76. A collar 36 may be disposed about each of the fingers 34 of the coupler assembly 32 to further assist in coupling, engaging, attaching, and/or otherwise holding together the fingers 34 and the buckle members 58. Some suitable but non-limiting materials for the coupler assembly 32, the fingers 34, the collars 36, and/or the guides 38, for example metallic materials or polymeric materials, may be described below.

In some embodiments, the plurality of valve leaflets 16 may be secured to the tubular anchor member 40 at, proximate to, and/or using (at least in part) individual, corresponding post members 76. In some embodiments, the plurality of valve leaflets 16 may also be secured to the distal end of the tubular anchor member 40. In at least some embodiments, the distal end of the tubular anchor member 40 may be interchangeably described as the “inflow” end or the “upstream” end of the tubular anchor member 40 and/or the medical implant 14. In at least some embodiments, the proximal end of the tubular anchor member 40 may be interchangeably described as the “outflow” end or the “downstream” end of the tubular anchor member 40 and/or the medical implant 14.

As will be described in more detail below, the post member 76 may be secured, attached, coupled, and/or connected to the distal end and/or the inflow end of the tubular anchor member 40. Therefore, in some embodiments, when the post member 76 is pulled proximally to engage the buckle member 58, as will be described herein, the distal end and/or the inflow end of the tubular anchor member 40 is also pulled proximally relative to the buckle member 58, thereby transitioning from the “delivery” configuration and/or the “everted” configuration toward the “deployed” configuration. In some embodiments, the plurality of valve leaflets 16 may be coupled and/or secured (e.g., to the post member 76, to the tubular anchor member 40, and/or back to themselves) using at least one suture, thread, wire, filament, or other suitable element. In some embodiments, the plurality of valve leaflets 16 may be coupled and/or secured (e.g., to the post member 76, to the tubular anchor member 40, and/or back to themselves) using an adhesive, a bonding agent, or other suitable securing means. In some embodiments, the plurality of valve leaflets 16 may be coupled and/or secured (e.g., to the post member 76, to the tubular anchor member 40, and/or back to themselves) using a fabric strip, a textile, or other thin flexible material. In some embodiments, the plurality of valve leaflets 16 may not be directly attached to the tubular anchor member 40.

In some embodiments, a seal member 44 may be circumferentially disposed on and/or about a distal portion and/or an inflow portion of the tubular anchor member 40, as seen in FIG. 2 for example, and as the term suggests, may help to seal an exterior of the medical implant 14 and/or the tubular anchor member 40 within and/or against a target site or area of interest upon deployment (e.g., in the “deployed” configuration and/or the “released” configuration), thereby inhibiting or preventing leakage around the medical implant 14 and/or the tubular anchor member 40. In some embodiments, the seal member 44 may be disposed about and/or radially outward of an outside surface of the tubular anchor member 40. In some embodiments, the seal member 44 may be disposed around a perimeter and/or on or against an exterior or outer surface of the tubular anchor member 40. In some embodiments, the seal member 44 may be coupled and/or secured at the distal end and/or the inflow end of the tubular anchor member 40.

In some embodiments, the seal member 44 may include a plurality of layers of polymeric material. Some suitable polymeric materials may include, but are not necessarily limited to, polycarbonate, polyurethane, polyamide, polyether block amide, polyethylene, polyethylene terephthalate, polypropylene, polyvinylchloride, polytetrafluoroethylene, polysulfone, and copolymers, blends, mixtures or combinations thereof. Other configurations and/or other suitable materials are also contemplated.

In some embodiments, the modulus of elasticity may vary and/or be different from layer to layer. In other embodiments, the elongation to break may vary and/or be different from layer to layer. In some embodiments, the seal member 44 may also include a reinforcement, a reinforcing layer, and/or at least one reinforcing member added to the polymeric material prior to curing. The reinforcement, the reinforcing layer, and/or the at least one reinforcing member may comprise a woven or nonwoven fabric and may be positioned within or between the various layers. In some embodiments, the reinforcement, the reinforcing layer, and/or the at least one reinforcing member may be positioned on a radially innermost surface or radially outermost surface of the seal member 44. In some embodiments, the reinforcement, the reinforcing layer, and/or the at least one reinforcing member may be generally aligned. In some embodiments, the reinforcement, the reinforcing layer, and/or the at least one reinforcing member may be randomly oriented and/or disposed on the seal member 44.

In some embodiments, a distal end of the seal member 44 may include a reinforcing band fixedly attached to the seal member 44 at and/or proximate the distal end and/or the inflow end of the tubular anchor member 40. In some embodiments, the reinforcing band may be integrally formed with, incorporated into, adhered to, and/or at least partially embedded within the seal member 44. In some embodiments, the reinforcing band may be formed from a woven or nonwoven fabric strip, a textile, or other thin flexible material. The reinforcing band may provide tear resistance in the vicinity of sutures, filaments, or other attachment elements associated with components or aspects of the medical implant 14. In some embodiments, the seal member 44 and/or the reinforcing band may extend longitudinally beyond the distal end and/or the inflow end of the tubular anchor member 40.

In some embodiments, the plurality of valve leaflets 16 may each define a secured end and a free end opposite the secured end, wherein the free ends of the plurality of valve leaflets 16 come together to define an outflow end of a valve disposed within the tubular anchor member 40 in the “deployed” configuration. In some embodiments, the secured end of each of the plurality of valve leaflets 16 may be directly attached to the seal member 44 and/or the reinforcing band at and/or proximate the distal end and/or the inflow end of the tubular anchor member 40. In some embodiments, the plurality of valve leaflets 16 may not be attached directly to the distal end and/or the inflow end of the tubular anchor member 40. In some embodiments, the plurality of valve leaflets 16 may be configured to shift between a deployed position wherein the outflow end of the valve is disposed within the tubular anchor member 40, and an everted position wherein the outflow end of the valve is disposed outside of, distal of, and/or upstream of the tubular anchor member 40.

As shown in FIG. 3, a buckle member 58 may include a proximal end and a distal end disposed opposite the proximal end. In some embodiments, the buckle member 58 may include a back wall extending from the proximal end to the distal end. In some embodiments, the buckle member 58 may include two axially-extending side walls extending radially inward toward the central longitudinal axis away from the back wall and/or the tubular anchor member 40, when the buckle member 58 is attached thereto. In some embodiments, the back wall may be configured to engage a radially inner surface of the tubular anchor member 40. In an example, the back wall may be configured to matingly engage the radially inner surface of the tubular anchor member 40 such that the back wall is disposed radially distant from the central longitudinal axis of the medical implant 14 relative to the two side walls. In some embodiments, the back wall may include a generally planar inner surface facing toward the central longitudinal axis when the buckle member 58 is fixedly attached and/or secured to the tubular anchor member 40. In some embodiments, the back wall may include a curved outer surface configured to mate with and/or lie against an inner surface of the tubular anchor member 40 when the buckle member 58 is fixedly attached and/or secured to the tubular anchor member 40.

In some embodiments, the two axially-extending side walls may include a first side wall and a second side wall. In some embodiments, each side wall may include a proximal upper flange 57 and a distal upper flange 59 spaced longitudinally apart from the proximal upper flange 57, the proximal upper flange 57 and the distal upper flange 59 each extending from a top of the side wall distant from the back wall, the proximal upper flange 57 and the distal upper flange 59 each extending inwardly toward a central plane through the buckle member 58 (and/or the central longitudinal axis) normal to the back wall and/or the generally planar inner surface. In at least some embodiments, the proximal upper flange 57 and the distal upper flange 59 each may be oriented generally parallel to the back wall and/or the generally planar inner surface of the back wall. In some embodiments, the distal upper flange(s) 59 may define a proximal locking face configured to engage a latch portion extending laterally from the post member 76, as described herein.

In some embodiments, the back wall may extend between the two side walls, such that the two side walls, the back wall, and/or the proximal upper flange(s) 57 and the distal upper flange(s) 59 define a channel extending axially through the buckle member 58. In some embodiments, the buckle member 58 and/or the channel may include a suitable shape and/or keying feature(s) configured to cooperate with the actuator member 50 and/or the post member 76 to prevent relative rotation between the actuator member 50 and/or the post member 76 and the buckle member 58. In some embodiments, the back wall may include at least one aperture disposed within the back wall and between the two side walls. In some embodiments, a fastening element (e.g., a suture, thread, wire, filament, etc.) may pass through the at least one aperture and secure the buckle member 58 to the tubular anchor member 40. In some embodiments, the back wall may include a recessed portion in communication with some or all of the at least one aperture of the buckle member 58.

In some embodiments, the buckle member 58 may be substantially rigid. In some embodiments, the buckle member 58 may be formed from a metallic material, a polymeric material, a ceramic material, a composite material, or other suitable materials or combinations thereof. In some embodiments, the buckle member 58 may be partially rigid and/or partially flexible. In some embodiments, a buckle member 58 may permit an actuator member 50 and/or a post member 76 to be slidably received within and/or axially translate through the channel. In some embodiments, the buckle member 58 may be configured to prevent the actuator member 50 and/or the post member 76 from exiting the buckle member 58 in a radially inward direction toward the central longitudinal axis of the tubular anchor member 40, thereby limiting motion of the actuator member 50 and/or the post member 76 within the tubular anchor member 40 to axial translation.

As seen in FIG. 4, an example post member 76 may include a proximal end and a distal end, wherein the proximal end and the distal end may be defined based upon the orientation of the post member 76 when the medical implant 14 and/or the tubular anchor member 40 is in the “deployed” configuration and/or the “released” configuration. In some embodiments, the post member 76 may include a central body portion extending from the proximal end to the distal end, the central body portion being oriented generally along a first plane. In some embodiments, when the post member 76 is engaged with the buckle member 58, the central body portion may be oriented generally parallel to the generally planar inner surface of the back wall of the buckle member 58.

In some embodiments, the post member 76 may include a latch portion 80 connected to and/or integrally formed with or as a part of the central body portion. In some embodiments, the central body portion may be a laterally-arched central body portion extending laterally away from the first plane to form the latch portion 80. In some embodiments, the latch portion 80 may be resilient and/or self-biased away from the first plane. In some embodiments, the latch portion 80 may be configured to be deflected by the buckle member 58 and/or the distal upper flange(s) 59 as the post member 76 is translated proximally through the buckle member 58 and/or past the distal upper flange(s) 59.

In some embodiments, the post member 76 (in association and/or cooperation with axial translation of the actuator member 50) may be reversibly actuatable between a first orientation, wherein the proximal end extends distally from the central body portion (e.g., in the “delivery” and/or “everted” configuration), and a second orientation, wherein the proximal end extends proximally from the central body portion. In some embodiments, the post member 76 may be positioned and/or oriented in the second orientation in at least one configuration, including but not limited to, the “deployed” and/or “released” configurations. In some embodiments, the post member 76 may be axially translatable relative to the buckle member 58 and/or the tubular anchor member 40.

In some embodiments, the post member 76 may include a cantilevered leg 84 connected by a flexible hinge portion 82 at the distal end of the post member 76. In some embodiments, the cantilevered leg 84 may extend proximally from the hinge portion 82 and/or the distal end to a free end of the cantilevered leg 84 disposed radially inward from the central body portion and/or the latch portion 80 (relative to the tubular anchor member 40), when the post member 76 is in the second orientation. In some embodiments, the free end may be disposed proximal of the latch portion 80 when the post member 76 is in the second orientation. In some embodiments, the latch portion 80 may be disposed proximal of the distal end and/or the hinge portion 82 when the post member 76 is in the second orientation. In some embodiments, the cantilevered leg 84 may extend distally from the hinge portion 82 and/or the distal end to the free end of the cantilevered leg 84 disposed radially outward from the central body portion and/or the latch portion 80 (relative to the tubular anchor member 40), when the post member 76 is in the first orientation. In some embodiments, the free end may be disposed distal of the latch portion 80 when the post member 76 is in the first orientation. In some embodiments, the latch portion 80 may be disposed distal of the distal end and/or the hinge portion 82 when the post member 76 is in the first orientation.

In some embodiments, the hinge portion 82 may have and/or include a radius of curvature. For example, in some embodiments, the radius of curvature may be between 0 and 3 millimeters (mm). In some embodiments, the radius of curvature may be an inner radius of curvature of between 0 and 3 millimeters (mm). In some embodiments, the radius of curvature may be an outer radius of curvature of between 0 and 3 millimeters (mm). Other configurations and radii of curvature are also contemplated. In some embodiments, the hinge portion 82 may be configured to dispose the central body portion and the cantilevered leg 84 at an acute angle relative to each other. In some embodiments, the acute angle may be between about 0 degrees and about 90 degrees, between about 3 degrees and about 60 degrees, between about 5 degrees and about 45 degrees, between about 8 degrees and about 30 degrees, between about 10 degrees and about 20 degrees, between about 12 degrees and about 16 degrees, about 14 degrees, or another suitable angle. In at least some embodiments, the hinge portion 82 flexibly attaches the cantilevered leg 84 to the central body portion of the post member 76. In some embodiments, at least part of the cantilevered leg 84 may longitudinally overlap the buckle member 58 along a central longitudinal axis of the tubular anchor member 40 in the “deployed” configuration.

In some embodiments, the cantilevered leg 84 may include a free end and a secured end, where the cantilevered leg 84 may be attached to the central body portion and/or the distal end of the post member 76 at the secured end of the cantilevered leg 84, which may connect directly to the hinge portion 82. In some embodiments, the free end of the cantilevered leg 84 may be unattached (e.g., not directly attached) to any other structure of the medical implant 14, except for the cantilevered leg 84 and/or the plurality of valve leaflets 16. In other words, in some embodiments, the free end of the cantilevered leg 84 may not be directly attached to any other structure or feature of the medical implant 14 (e.g., the buckle member 58, the tubular anchor member 40, etc.). In some embodiments, the distal end of the post member 76, which in at least some embodiments may be proximate to and/or include the hinge portion 82, may be coupled to the distal end of the tubular anchor member 40, such as, for example, by a fastening element such as a suture, a filament, a wire, or other suitable means, as described herein. In some embodiments, the central body portion may include at least one aperture or hole 86 configured to receive a coupling element therethrough for securing the post member 76 to a distal end of the tubular anchor member 40, such as the suture, for example. As such, when the post member 76 is pulled proximally to engage the buckle member 58, the distal end of the tubular anchor member 40 is also pulled proximally relative to the buckle member 58, thereby transitioning from the “delivery” configuration toward the “deployed” configuration.

In some embodiments, the cantilevered leg(s) 84 may include a first longitudinally-oriented slot 85 extending therethrough between the secured end of the cantilevered leg 84 and the free end of the cantilevered leg 84. In at least some embodiments, at least one of the plurality of valve leaflets 16 may be coupled to and/or attached to the cantilevered leg(s) 84. In some embodiments, at least one of the plurality of valve leaflets 16 extend through the first longitudinally-oriented slot 85 of the cantilevered leg(s) 84. In some embodiments, attachment of the plurality of valve leaflets 16 to the cantilevered leg(s) 84 may provide flexibility and/or a reduction in stress between the plurality of valve leaflets 16 and the tubular anchor member 40. In some embodiments, at least a portion of the plurality of valve leaflets 16 may axially or longitudinally overlap at least a portion of the buckle members 58 at a common position along a central longitudinal axis of the tubular anchor member 40, which in some embodiments may allow for a shorter overall length or height of the medical implant 14. In some embodiments, the plurality of valve leaflets 16 may be secured directly to the cantilevered leg(s) 84. In some embodiments, the plurality of valve leaflets 16 may not be directly secured to the central body portion of the post member 76, but is instead coupled to the post member 76 via the cantilevered leg(s) 84. In some embodiments, the plurality of valve leaflets 16 may be wrapped around at least a portion of the cantilevered leg(s) 84. In some embodiments, a distalmost end of the plurality of valve leaflets 16 may be coupled to the distal end of the tubular anchor member 40. In some embodiments, the plurality of valve leaflets 16 may be coupled and/or secured (e.g., to the cantilevered leg 84, to the tubular anchor member 40, and/or back to themselves) using at least one suture, thread, wire, filament, or other suitable element. In some embodiments, the plurality of valve leaflets 16 may be coupled and/or secured (e.g., to the cantilevered leg 84, to the tubular anchor member 40, and/or back to themselves) using an adhesive, a bonding agent, or other suitable securing means. In some embodiments, the plurality of valve leaflets 16 may be coupled and/or secured (e.g., to the cantilevered leg 84, to the tubular anchor member 40, and/or back to themselves) using a fabric, a textile, or other thin flexible material.

In some embodiments, the post member 76 may include a receiving portion 88 proximate the proximal end. In some embodiments, the receiving portion 88 may include a first portion 81 and a second portion 83, each extending proximally from the central body portion and/or the latch portion 80 when the post member 76 is in the second orientation. In some embodiments, the first portion 81 and the second portion 83 may be spaced apart by a second longitudinally-oriented slot 87 disposed therebetween. In some embodiments, the second longitudinally-oriented slot 87 may narrow distally when the post member 76 is in the second orientation. In some embodiments, each of the first portion 81 and the second portion 83 may include an aperture 89 extending into and/or from the second longitudinally-oriented slot 87 such that the aperture 89 of each respective portion is in communication with the second longitudinally-oriented slot 87. In some embodiments, the aperture 89 of the first portion 81 and/or the aperture 89 of the second portion 83 may extend partially through its respective portion in a radial (with respect to the central longitudinal axis and/or the tubular anchor member 40) direction. In some embodiments, the aperture 89 of the first portion 81 and/or the aperture 89 of the second portion 83 may extend completely through its respective portion in a radial (with respect to the central longitudinal axis and/or the tubular anchor member 40) direction. In some embodiments, the first portion 81 and the second portion 83 may be configured to releasably engage the actuator member 50, thereby releasably connecting the actuator member 50 to the proximal end of the post member 76. In some embodiments, as the actuator member 50 and/or the post member 76 is translated proximally through the buckle member 58 in the second orientation, the second longitudinally-oriented slot 87 of the post member 76 may contact and/or engage a distal end of the finger of the coupler assembly 32. In some embodiments, the distal end of the finger may be configured to splay apart the first portion 81 and the second portion 83 by forcing the first portion 81 radially inward toward the central longitudinal axis relative to, and/or away from, the second portion 83 as the post member 76 is translated proximally when the first portion 81 contacts the finger, as seen in FIGS. 11 and 12 for example.

In some embodiments, the latch portion 80 may be configured to engage the proximal locking face of the distal upper flange(s) 59 of the buckle member 58 when the post member 76 is in the second orientation, such that axial movement of the post member 76 distally relative to the buckle member 58 is prevented when the medical implant 14 and/or the tubular anchor member 40 is in the “deployed” configuration and/or the “released” configuration. In some embodiments, the latch portion 80 may include a transversely-oriented tooth extending laterally (or radially relative to the central longitudinal axis) therefrom and/or extends toward the cantilevered leg 84, wherein the tooth is configured to engage with the proximal locking face of the distal upper flange(s) 59 when the post member 76 is in the second orientation and/or the tubular anchor member 40 is in the “deployed” configuration and/or the “released” configuration. In some embodiments, the central body portion arches laterally (or radially relative to the central longitudinal axis) in a first direction relative to the proximal end and the distal end of the post member 76 (e.g., relative to the first plane), and the latch portion 80 and/or the tooth extends laterally (or radially relative to the central longitudinal axis) in the first direction from the central body portion.

In some embodiments, at least a portion of the post member 76 is flexible. In some embodiments, the latch portion 80 and/or the tooth may be movable relative to the central body portion. In some embodiments, the latch portion 80 may be deflectable relative to the central body portion such that the latch portion 80 and/or the tooth may translate laterally relative to the central body portion and/or radially outward relative to the central longitudinal axis. In some embodiments, the central body portion and/or the latch portion 80 may be configured to flex towards the first plane and/or a substantially straight configuration (e.g., radially relative to the central longitudinal axis) upon proximal translation of the post member 76 through the buckle member 58. In some embodiments, the free end of the cantilevered leg 84 may be movable toward and away from the central body portion (e.g., radially relative to the central longitudinal axis) by bending and/or pivoting the cantilevered leg 84 at and/or using the hinge portion 82.

In some embodiments, the central body portion may be unitary with and/or integrally formed with the latch portion 80, the hinge portion 82, the cantilevered leg 84, the receiving portion 88, and/or the first portion 81 and the second portion 83, of the post member 76 as and/or from a single piece of material. In some embodiments, the post member 76 may be formed from a single piece of wire, flat stock, or other suitable material as discussed herein. In some embodiments, the post member 76 may be formed by further processing the single piece of wire, flat stock, or other suitable material, such as by machining, stamping, laser cutting, or other suitable techniques.

In some embodiments, an example actuator member 50, as seen in FIG. 5 for example, may include a proximal end and a distal end. In some embodiments, the actuator member 50 may include a proximal shaft portion 52 and a distal engagement portion 56 configured to be releasably engaged with and/or connected to the proximal end, the receiving portion 88, the first portion 81, and/or the second portion 83, of the post member 76. In some embodiments, the proximal shaft portion 52 may be pivotable with respect to the distal engagement portion 56. In some embodiments, the actuator member 50 may include a hinge element 54 disposed between the proximal shaft portion 52 and the distal engagement portion 56. In some embodiments, the hinge element 54 may include a pivot pin, or a plurality of pivot pins, fixedly attached to one of the proximal shaft portion 52 and the distal engagement portion 56, and a receiving element configured to pivotably engage the pivot pin, or the plurality of pivot pins, fixedly attached to the other one of the proximal shaft portion 52 and the distal engagement portion 56.

In some embodiments, the distal engagement portion 56 may include a lateral protrusion 60 proximate a distal end thereof. In some embodiments, the distal engagement portion 56 may include more than one lateral protrusion 60 proximate a distal end thereof. In some embodiments, the lateral protrusion 60 may be configured to matingly engage with the receiving portion 88, the aperture 89 of the first portion 81, and/or the aperture 89 of the second portion 83 of the post member 76. In some embodiments, the actuator member 50 may be prevented from rotating (e.g., is non-rotatable) relative to the post member 76 when the distal engagement portion 56 and/or the lateral protrusion 60 of the actuator member 50 is engaged with the receiving portion 88, the aperture 89 of the first portion 81, and/or the aperture 89 of the second portion 83 of the post member 76. In some embodiments, the actuator member 50 may be prevented from rotating (e.g., is non-rotatable) relative to the buckle member 58 when the distal engagement portion 56 and/or the lateral protrusion 60 of the actuator member 50 is engaged with the receiving portion 88, the aperture 89 of the first portion 81, and/or the aperture 89 of the second portion 83 of the post member 76, and/or when the post member 76 is engaged with the buckle member 58.

In use, the proximal end of the actuator member 50 may be connected to and/or manipulated or otherwise actuated by a user, for example using the handle 18, to shift the medical implant 14 from a “delivery” configuration and/or an “everted” configuration to a “deployed” configuration, and later to a “released” configuration. In some embodiments, the actuator member 50 may be axially translatable relative to the buckle member 58. In some embodiments, the actuator member 50 may extend through the channel of the buckle member 58 when the tubular anchor member 40 is in the “delivery” configuration and/or the “everted” configuration. In some embodiments, the actuator member 50 may extend distally of the tubular anchor member 40 in the “delivery” configuration and/or the “everted” configuration. In some embodiments, the actuator member 50 may be axially translatable within and/or through the channel of the buckle member 58 to engage the post member 76 with the buckle member 58.

In some embodiments, the actuator member 50 may be aligned with the post member 76 and/or the lateral protrusion(s) 60 may be releasably engaged with and/or connected to the proximal end of the post member 76 and/or the receiving portion 88, the aperture 89 of the first portion 81, and/or the aperture 89 of the second portion 83 of the post member 76. In some embodiments, the distal engagement portion 56 may be received within the second longitudinally-oriented slot 87 disposed between the first portion 81 and the second portion 83 of the post member 76. In some embodiments, the lateral protrusion(s) 60 may be configured to engage with, be received by, and/or extend into the aperture(s) 89 formed within each of the first portion 81 and the second portion 83 of the post member 76.

In some embodiments, the actuator member 50 and/or the proximal shaft portion 52 may be generally round, oblong, ovoid, rectangular, polygonal (e.g., two-sided, three-sided, four-sided, five-sided, six-sided, etc.) in shape. Other shapes, both regular and irregular, are also contemplated. For example, in some embodiments, the proximal shaft portion 52 may include a flattened portion or side oriented radially inward toward the central longitudinal axis. In some embodiments, the actuator member 50 may be formed from a single piece of wire, round stock, or other suitable material, as discussed herein. In some embodiments, the actuator member 50 may be formed by further processing the single piece of wire, round stock, or other suitable material, such as by machining, stamping, laser cutting, or other suitable techniques. Some suitable but non-limiting materials for the actuator member 50, the proximal shaft portion 52, the distal engagement portion 56, and/or the hinge element 54, for example metallic materials or polymeric materials, may be described below.

FIGS. 6-13 illustrate the general relationship and operation of selected components of a locking mechanism configured to lock the medical implant 14 (and/or the tubular anchor member 40) in the “deployed” configuration and/or the “released” configuration.

During delivery, after the medical implant 14 is advanced within the anatomy to the desired and/or target location, at least a portion of the delivery system 12 may be withdrawn (e.g., moved proximally relative to the medical implant 14) to expose the medical implant 14 in the “delivery” configuration and/or the “everted” configuration. FIG. 6 illustrates selected elements of the medical implant system 10 in the “delivery” configuration and/or the “everted” configuration. In the “delivery” configuration and/or the “everted” configuration, the plurality of valve leaflets 16 may extend and/or be positioned distally of and/or away from the tubular anchor member 40. In some embodiments, in the “delivery” configuration and/or the “everted” configuration, the plurality of actuator members 50 may extend distally of, away from, and/or completely through the tubular anchor member 40, and/or the plurality of post members 76 may extend distally of and/or away from the tubular anchor member 40, as seen in FIG. 6 for example.

In some embodiments, a distal end of the axially movable post member 76 may be secured and/or attached (e.g., fixedly attached, movably attached, removably attached, etc.) to a distal portion of the tubular anchor member 40, such as by a suture 74, a tether, adhesives, or other suitable element. In some embodiments, the commissure post and/or the post member 76 may include at least one hole 86 (as seen in FIG. 4 for example) or other features provided to aid in securing and/or attaching the commissure post and/or the post member 76 to the tubular anchor member 40. For example, in some embodiments, the suture 74 may pass through the at least one hole 86 in the post member 76 and/or the suture 74 may be secured to the post member 76 using the at least one hole 86.

In some embodiments, the post member 76 may be movable relative to the tubular anchor member 40 and/or the buckle member 58. In some embodiments, the post member 76 may be axially or longitudinally movable relative to the tubular anchor member 40 and/or the buckle member 58. In some embodiments, the buckle member 58 may be fixedly attached to the tubular anchor member 40 at and/or proximate the proximal end thereof. Other embodiments are contemplated where the buckle member 58 may be movably or removably attached to the tubular anchor member 40. In some embodiments, the post member 76 may be movably or removably attached to the tubular anchor member 40 and the buckle member 58 may be movably or removably attached to the tubular anchor member 40. In some embodiments, the post member 76 may be secured or attached (e.g., fixedly attached, movably attached, removably attached, etc.) to a distal end of the tubular anchor member 40.

As seen in FIG. 6, when the medical implant 14 and/or the tubular anchor member is in the “delivery” configuration and/or the “everted” configuration, the distal engagement portion 56 of the actuator member 50 extends proximally from the hinge element 54 of the actuator member 50, and the post member 76 is in the first orientation. Similarly, when the medical implant 14 and/or the tubular anchor member 40 is in the “delivery” configuration and/or the “everted” configuration, the cantilevered leg 84 of the post member 76 extends radially outward from the hinge portion 82 and/or the central body portion. The plurality of valve leaflets 16 may be disposed distally of the tubular anchor member 40. In some embodiments, having the plurality of valve leaflets 16 and the plurality of post members 76 disposed outside of the tubular anchor member 40 may permit the tubular anchor member 40 to be collapsed to a smaller overall diameter and/or size for delivery due to less structure being disposed within the lumen of the tubular anchor member 40.

Turning now to FIG. 7, a user has manipulated and/or operated the handle 18 to partially withdraw the actuator member 50 through the buckle member 58, thereby drawing the post member 76 towards the buckle member 58. As may be seen in the figure, the post member 76 has begun to transition away from the first orientation and towards the second orientation. The medical implant 14 and/or the tubular anchor member 40 may thus be understood to be in a partially-everted configuration and/or a partially-deployed configuration. In the partially-everted configuration and/or the partially-deployed configuration, at least some portions of the post member 76 (e.g., the receiving portion, the first portion, the second portion, etc.) may extend radially inward toward the central longitudinal axis from the distal end of the post member 76. For example, the free end of the cantilevered leg 84 and/or the proximal end of the post member 76 may be positioned radially inward of the distal end of the post member 76 and/or the tubular anchor member 40.

FIG. 8 illustrates selected components of the medical implant system 10 in a partially deployed configuration. Here it may be seen that the actuator member 50 has been retracted proximally, such that the distal engagement portion 56 has pivoted relative to the proximal shaft portion 52 at and/or about the hinge element 54 until the post member 76 is oriented in the second orientation to permit a smooth transition into the channel of the buckle member 58. In some embodiments, when the post member 76 is oriented in the second orientation, the proximal shaft portion 52 and the distal engagement portion 56 are coaxial with each other and/or the post member 76.

FIG. 9 illustrates selected components in cross-section of the medical implant system 10 in a partially deployed configuration. As shown in the figure, as the actuator member 50 is translated proximally through the buckle member 58, the proximal end of the post member 76 may engage the buckle member 58 and be pulled into the channel thereof. As the latch portion 80 and/or the tooth approaches a distally facing surface of the distal upper flange(s) 59, the latch portion 80 and/or the tooth contacts the distally facing surface and the distally facing surface begins to interfere with proximal translation of the actuator member 50 and/or the post member 76. A user may notice and/or detect an increase in force as friction and/or interference between the latch portion 80 and/or the tooth and the distal upper flange(s) 59 of the buckle member 58 is generated. In some embodiments, a user may use this increase in force as a cue to re-assess the location and/or progress of the deployment, such as by a visualization means. If the placement is unsatisfactory, the user may reverse the direction of translation of the actuator member 50, and actuate the medical implant 14 and/or the tubular anchor member 40 toward the “delivery” configuration for repositioning and/or complete withdrawal, if necessary. If the placement is satisfactory, the user may continue using the handle 18 to translate the actuator member 50 and/or the post member 76 proximally until the latch portion 80 and/or the tooth has passed the distal upper flange(s) 59 of the buckle member 58, thereby placing the medical implant 14 and/or the tubular anchor member 40 in the “deployed” configuration, as seen in FIG. 10 for example.

FIG. 10 illustrates the proximal end of the post member 76 engaged with the buckle member 58 after further proximal retraction of the actuator member 50 through the buckle member 58. After the latch portion 80 and/or the tooth has passed the distal upper flange(s) 59 of the buckle member 58, contact between the latch portion 80 and/or the tooth and the proximally facing surface of the distal upper flange(s) 59 may prevent distal translation of the medical implant 14 and/or the tubular anchor member 40 toward the “delivery” configuration. In at least some embodiments, with the post member 76 engaged with the buckle member 58, the post member 76 may be positioned in the second orientation.

As seen in FIGS. 11 and 12, further proximal translation and/or retraction of the actuator member 50 relative to the buckle member 58 results in the receiving portion 88, and/or the first portion 81 and the second portion 83, of the post member 76 contacting and/or engaging a distal end of the finger 34. Continued proximal translation and/or retraction of the actuator member 50 may splay apart the receiving portion 88, and/or first portion 81 and the second portion 83, of the post member 76 as the distal end of the finger 34 extends into the second longitudinally-oriented slot 87, thereby disengaging the distal engagement portion 56 and/or the lateral protrusion(s) 60 of the actuator member 50 from the aperture(s) 89 in the receiving portion 88, and/or the aperture 89 in the first portion 81 and the aperture 89 in the second portion 83, of the post member 76.

Simultaneously with and/or immediately before splaying apart the receiving portion 88, and/or the first portion 81 and the second portion 83, of the post member 76 and/or disengagement of the distal engagement portion 56 and/or the lateral protrusion(s) 60 of the actuator member 50 from the aperture(s) 89 in the receiving portion 88, and/or the aperture 89 in the first portion 81 and the aperture 89 in the second portion 83, of the post member 76, a proximal face along a top or radially-inward facing side of the proximal shaft portion 52 of the actuator member 50 proximate to and/or proximal of the hinge element 54 may contact the collar 36, thereby proximally retracting the collar 36 along with the actuator member 50 to expose the finger 34 where it engages with the proximal end of the buckle member 58.

In some embodiments, after disengaging the distal engagement portion 56 and/or the lateral protrusion(s) 60 of the actuator member 50 from the aperture(s) 89 in the receiving portion 88, and/or the aperture 89 in the first portion 81 and the aperture 89 in the second portion 83, of the post member 76, the medical implant 14 and/or the tubular anchor member 40 may experience a minor or slight “spring-back” toward the “delivery” configuration. Additionally, since the collar 36 is no longer maintaining the finger 34 and the buckle member 58 in a coupled relationship or configuration, the finger(s) 34 and/or the coupler assembly 32 may separate from the medical implant 14, the buckle member(s) 58, and/or the tubular anchor member 40. As noted above, the latch portion 80 and/or the tooth may contact the proximally facing surface of the distal upper flange(s) 59, preventing the medical implant 14 and/or the tubular anchor member 40 from actuating further toward the “delivery” configuration. Upon separation and/or disengagement of the coupler assembly 32 from the medical implant 14, the medical implant 14 and/or the tubular anchor member 40 may be left in the “released” configuration, as seen in FIG. 13 for example, and the delivery system 12 may be withdrawn from the patient.

The materials that can be used for the various components of the medical implant system 10 (and/or other systems disclosed herein) and the various elements thereof disclosed herein may include those commonly associated with medical devices. For simplicity purposes, the following discussion makes reference to the delivery system 12 and/or the medical implant 14. However, this is not intended to limit the devices and methods described herein, as the discussion may be applied to other elements, members, components, or devices disclosed herein, such as, but not limited to, the tubular anchor member 40, the actuator member 50, the locking mechanism, the post member 76, the buckle member 58, and/or elements or components thereof.

In some embodiments, the delivery system 12 and/or the medical implant 14, and/or components thereof (such as, but not limited to, the tubular anchor member 40, the locking mechanisms, the actuator members 50, etc.), may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, ceramics, combinations thereof, and the like, or other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 444V, 444L, and 314LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R44035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R44003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; titanium; combinations thereof; and the like; or any other suitable material.

As alluded to herein, within the family of commercially available nickel-titanium or nitinol alloys, is a category designated “linear elastic” or “non-super-elastic” which, although may be similar in chemistry to conventional shape memory and super elastic varieties, may exhibit distinct and useful mechanical properties. Linear elastic and/or non-super-elastic nitinol may be distinguished from super elastic nitinol in that the linear elastic and/or non-super-elastic nitinol does not display a substantial “superelastic plateau” or “flag region” in its stress/strain curve like super elastic nitinol does. Instead, in the linear elastic and/or non-super-elastic nitinol, as recoverable strain increases, the stress continues to increase in a substantially linear, or a somewhat, but not necessarily entirely linear relationship until plastic deformation begins or at least in a relationship that is more linear than the super elastic plateau and/or flag region that may be seen with super elastic nitinol. Thus, for the purposes of this disclosure linear elastic and/or non-super-elastic nitinol may also be termed “substantially” linear elastic and/or non-super-elastic nitinol.

In some cases, linear elastic and/or non-super-elastic nitinol may also be distinguishable from super elastic nitinol in that linear elastic and/or non-super-elastic nitinol may accept up to about 2-5% strain while remaining substantially elastic (e.g., before plastically deforming) whereas super elastic nitinol may accept up to about 8% strain before plastically deforming. Both of these materials can be distinguished from other linear elastic materials such as stainless steel (that can also be distinguished based on its composition), which may accept only about 0.2 to 0.44 percent strain before plastically deforming.

In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy is an alloy that does not show any martensite/austenite phase changes that are detectable by differential scanning calorimetry (DSC) and dynamic metal thermal analysis (DMTA) analysis over a large temperature range. For example, in some embodiments, there may be no martensite/austenite phase changes detectable by DSC and DMTA analysis in the range of about −60 degrees Celsius (° C.) to about 120° C. in the linear elastic and/or non-super-elastic nickel-titanium alloy. The mechanical bending properties of such material may therefore be generally inert to the effect of temperature over this very broad range of temperature. In some embodiments, the mechanical bending properties of the linear elastic and/or non-super-elastic nickel-titanium alloy at ambient or room temperature are substantially the same as the mechanical properties at body temperature, for example, in that they do not display a super-elastic plateau and/or flag region. In other words, across a broad temperature range, the linear elastic and/or non-super-elastic nickel-titanium alloy maintains its linear elastic and/or non-super-elastic characteristics and/or properties.

In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy may be in the range of about 50 to about 60 weight percent nickel, with the remainder being essentially titanium. In some embodiments, the composition is in the range of about 54 to about 57 weight percent nickel. One example of a suitable nickel-titanium alloy is FHP-NT alloy commercially available from Furukawa Techno Material Co. of Kanagawa, Japan. Other suitable materials may include ULTANIUM™ (available from Neo-Metrics) and GUM METAL™ (available from Toyota). In some other embodiments, a superelastic alloy, for example a superelastic nitinol can be used to achieve desired properties.

In at least some embodiments, portions or all of the delivery system 12 and/or the medical implant 14, and/or components thereof, may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids a user in determining the location of the delivery system 12 and/or the medical implant 14. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands and/or coils may also be incorporated into the design of the delivery system 12 and/or the medical implant 14 to achieve the same result.

In some embodiments, a degree of Magnetic Resonance Imaging (MRI) compatibility is imparted into the medical implant 14. For example, the delivery system 12 and/or the medical implant 14, and/or components or portions thereof, may be made of a material that does not substantially distort the image and create substantial artifacts (e.g., gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. The delivery system 12 and/or the medical implant 14, or portions thereof, may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, cobalt-chromium-molybdenum alloys (e.g., UNS: R44003 such as ELGILOY®, PHYNOX®, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R44035 such as MP35-N® and the like), nitinol, and the like, and others.

In some embodiments, a sheath or covering (not shown) may be disposed over portions or all of the delivery system 12 and/or the medical implant 14. The sheath may be made from a polymer or other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the sheath can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6 percent LCP.

It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.

Claims

1. A locking mechanism for a medical implant, comprising: a buckle member;a post member axially translatable with respect to the buckle member, the post member including a receiving portion proximate a proximal end of the post member, a distal end, a laterally-arched central body portion extending between the receiving portion and the distal end, and a cantilevered leg extending proximally from the distal end; andan actuator element including a proximal shaft portion and a distal engagement portion, the distal engagement portion being configured to releasably engage the receiving portion of the post member;wherein the proximal shaft portion is pivotable with respect to the distal engagement portion.
2. The locking mechanism of claim 1, wherein the actuator element includes a hinge element disposed between the proximal shaft portion and the distal engagement portion.
3. The locking mechanism of claim 1, wherein the post member includes at least one aperture extending therethrough proximate the distal end, the at least one aperture being configured to receive a coupling element therethrough.
4. The locking mechanism of claim 1, wherein the distal engagement portion includes a lateral protrusion proximate a distal end of the distal engagement portion.
5. The locking mechanism of claim 4, wherein the lateral protrusion is configured to engage with an aperture disposed within the receiving portion.
6. The locking mechanism of claim 1, wherein the laterally-arched central body portion includes a tooth extending laterally therefrom.
7. The locking mechanism of claim 6, wherein the tooth extends toward the cantilevered leg.
8. The locking mechanism of claim 6, wherein the central body portion arches laterally in a first direction relative to the proximal end and the distal end, and the tooth extends laterally in the first direction from the central body portion.
9. The locking mechanism of claim 1, wherein the cantilevered leg includes a longitudinally-oriented slot extending therethrough.
10. The locking mechanism of claim 1, wherein the receiving portion includes a first portion and a second portion configured to splay apart as the post member is translated proximally within the buckle member to release the distal engagement portion therefrom.
11. The locking mechanism of claim 1, wherein the buckle member is formed of a substantially rigid material.
12. The locking mechanism of claim 1, wherein the central body portion is configured to flex towards a substantially straight configuration upon proximal translation through the buckle member.
13. A replacement heart valve implant, comprising: a tubular anchor member defining a central longitudinal axis;a plurality of locking mechanisms, each locking mechanism comprising: a buckle member fixedly attached to the tubular anchor member; anda post member axially translatable with respect to the buckle member, the post member including a receiving portion proximate a proximal end of the post member, a distal end, a laterally-arched central body portion extending between the receiving portion and the distal end, and a cantilevered leg extending proximally from the distal end;a plurality of valve leaflets, wherein each valve leaflet is coupled to the cantilevered leg of at least one of the plurality of locking mechanisms; anda plurality of actuator elements corresponding to the plurality of locking mechanisms, each actuator element including a proximal shaft portion and a distal engagement portion, wherein the proximal shaft portion is pivotable relative to the distal engagement portion, wherein the distal engagement portion is releasably fixed to the receiving portion of one post member.
14. The replacement heart valve implant of claim 13, wherein the buckle member of each locking mechanism is positioned against an inner surface of the tubular anchor member.
15. The replacement heart valve implant of claim 13, wherein the plurality of valve leaflets is configured to shift between an everted position wherein a free end of each of the plurality of valve leaflets is disposed distally of the tubular anchor member, and a deployed position wherein the free end of each of the plurality of valve leaflets is disposed within the tubular anchor member.
16. The replacement heart valve implant of claim 15, wherein in the everted position, each of the plurality of actuator elements extends distally of the tubular anchor member.
17. The replacement heart valve implant of claim 15, wherein each of the plurality of valve leaflets is secured to the tubular anchor member at a secured end opposite the free end.
18. A replacement heart valve implant, comprising: a tubular anchor member defining a central longitudinal axis, the tubular anchor member being configured to shift between a delivery configuration and a deployed configuration;a plurality of locking mechanisms, each locking mechanism comprising: a buckle member fixedly attached to the tubular anchor member; anda post member axially translatable with respect to the buckle member, the post member including a receiving portion proximate a proximal end of the post member, a distal end, a laterally-arched central body portion extending from the receiving portion to the distal end, and a cantilevered leg extending proximally from the distal end;a plurality of valve leaflets, wherein each valve leaflet is coupled to the cantilevered leg of at least one of the plurality of locking mechanisms, anda plurality of actuator elements corresponding to the plurality of locking mechanisms, each actuator element including a proximal shaft portion pivotably connected to a distal engagement portion, the distal engagement portion being releasably fixed to the receiving portion of one post member, wherein the distal engagement portion is configured to pivot with respect to the proximal shaft portion in a radial direction relative to the central longitudinal axis.
19. The replacement heart valve implant of claim 18, wherein each actuator element extends through the buckle member of its corresponding locking mechanism when the tubular anchor member is in the delivery configuration, and each actuator element is configured to translate the post member of its corresponding locking mechanism into engagement with the buckle member of its corresponding locking mechanism upon proximal retraction of the plurality of actuator elements.
20. The replacement heart valve implant of claim 18, wherein the post member is at least partially disposed distally of the tubular anchor member when the tubular anchor member is in the delivery configuration, and the post member is locked within the buckle member when the tubular anchor member is in the deployed configuration.

RELATED APPLICATIONS

This application claims priority to U.S. Provisional Application Ser. No. 62/336,944, filed May 16, 2016.

US Referenced Citations (833)

Number	Name	Date	Kind
15192	Peale	Jun 1856	A
2682057	Lord	Jun 1954	A
2701559	Cooper	Feb 1955	A
2832078	Williams	Apr 1958	A
3099016	Edwards	Jul 1963	A
3113586	Edmark, Jr.	Dec 1963	A
3130418	Head et al.	Apr 1964	A
3143742	Cromie	Aug 1964	A
3334629	Cohn	May 1967	A
3367364	Cruz, Jr. et al.	Feb 1968	A
3409013	Berry	Nov 1968	A
3445916	Schulte	May 1969	A
3540431	Mobin-Uddin	Nov 1970	A
3548417	Kischer et al.	Dec 1970	A
3570014	Hancock	Mar 1971	A
3587115	Shiley	Jun 1971	A
3592184	Watkins et al.	Jul 1971	A
3628535	Ostrowsky et al.	Dec 1971	A
3642004	Osthagen et al.	Feb 1972	A
3657744	Ersek	Apr 1972	A
3671979	Moulopoulos	Jun 1972	A
3714671	Edwards et al.	Feb 1973	A
3755823	Hancock	Sep 1973	A
3795246	Sturgeon	Mar 1974	A
3839741	Haller	Oct 1974	A
3868956	Alfidi et al.	Mar 1975	A
3874388	King et al.	Apr 1975	A
3997923	Possis	Dec 1976	A
4035849	Angell et al.	Jul 1977	A
4056854	Boretos et al.	Nov 1977	A
4106129	Carpentier et al.	Aug 1978	A
4222126	Boretos et al.	Sep 1980	A
4233690	Akins	Nov 1980	A
4265694	Boretos et al.	May 1981	A
4291420	Reul	Sep 1981	A
4297749	Davis et al.	Nov 1981	A
4323358	Lentz et al.	Apr 1982	A
4326306	Poler	Apr 1982	A
4339831	Johnson	Jul 1982	A
4343048	Ross et al.	Aug 1982	A
4345340	Rosen	Aug 1982	A
4373216	Klawitter	Feb 1983	A
4406022	Roy	Sep 1983	A
4423809	Mazzocco	Jan 1984	A
4425908	Simon	Jan 1984	A
4470157	Love	Sep 1984	A
4484579	Meno et al.	Nov 1984	A
4501030	Lane	Feb 1985	A
4531943	Van Tassel et al.	Jul 1985	A
4535483	Klawitter et al.	Aug 1985	A
4574803	Storz	Mar 1986	A
4580568	Gianturco	Apr 1986	A
4592340	Boyles	Jun 1986	A
4602911	Ahmadi et al.	Jul 1986	A
4605407	Black et al.	Aug 1986	A
4610688	Silvestrini et al.	Sep 1986	A
4612011	Kautzky	Sep 1986	A
4617932	Kornberg	Oct 1986	A
4643732	Pietsch et al.	Feb 1987	A
4647283	Carpentier et al.	Mar 1987	A
4648881	Carpentier et al.	Mar 1987	A
4655218	Kulik et al.	Apr 1987	A
4655771	Wallsten	Apr 1987	A
4662885	Dipisa, Jr.	May 1987	A
4665906	Jervis	May 1987	A
4680031	Alonso	Jul 1987	A
4692164	Dzemeshkevich et al.	Sep 1987	A
4705516	Barone et al.	Nov 1987	A
4710192	Liotta et al.	Dec 1987	A
4733665	Palmaz	Mar 1988	A
4755181	Igoe	Jul 1988	A
4759758	Gabbay	Jul 1988	A
4777951	Cribier et al.	Oct 1988	A
4787899	Lazarus	Nov 1988	A
4787901	Baykut	Nov 1988	A
4796629	Grayzel	Jan 1989	A
4819751	Shimada et al.	Apr 1989	A
4829990	Thuroff et al.	May 1989	A
4834755	Silvestrini et al.	May 1989	A
4851001	Taheri	Jul 1989	A
4856516	Hillstead	Aug 1989	A
4865600	Carpentier et al.	Sep 1989	A
4872874	Taheri	Oct 1989	A
4873978	Ginsburg	Oct 1989	A
4878495	Grayzel	Nov 1989	A
4878906	Lindemann et al.	Nov 1989	A
4883458	Shiber	Nov 1989	A
4885005	Nashef et al.	Dec 1989	A
4909252	Goldberger	Mar 1990	A
4917102	Miller et al.	Apr 1990	A
4922905	Strecker	May 1990	A
4927426	Dretler	May 1990	A
4954126	Wallsten	Sep 1990	A
4966604	Reiss	Oct 1990	A
4969890	Sugita et al.	Nov 1990	A
4979939	Shiber	Dec 1990	A
4986830	Owens et al.	Jan 1991	A
4994077	Dobben	Feb 1991	A
5002556	Ishida et al.	Mar 1991	A
5002559	Tower	Mar 1991	A
5007896	Shiber	Apr 1991	A
5026366	Leckrone	Jun 1991	A
5032128	Alonso	Jul 1991	A
5037434	Lane	Aug 1991	A
5047041	Samuels	Sep 1991	A
5064435	Porter	Nov 1991	A
5080668	Bolz et al.	Jan 1992	A
5085635	Cragg	Feb 1992	A
5089015	Ross	Feb 1992	A
5132473	Furutaka et al.	Jul 1992	A
5141494	Danforth et al.	Aug 1992	A
5152771	Sabbaghian et al.	Oct 1992	A
5159937	Tremulis	Nov 1992	A
5161547	Tower	Nov 1992	A
5163953	Vince	Nov 1992	A
5167628	Boyles	Dec 1992	A
5209741	Spaeth	May 1993	A
5215541	Nashef et al.	Jun 1993	A
5217483	Tower	Jun 1993	A
5238004	Sahatjian et al.	Aug 1993	A
5258023	Reger	Nov 1993	A
5258042	Mehta	Nov 1993	A
5282847	Trescony et al.	Feb 1994	A
5295958	Shturman	Mar 1994	A
5332402	Teitelbaum	Jul 1994	A
5336258	Quintero et al.	Aug 1994	A
5350398	Pavcnik et al.	Sep 1994	A
5360444	Kusuhara	Nov 1994	A
5370685	Stevens	Dec 1994	A
5389106	Tower	Feb 1995	A
5397351	Pavcnik et al.	Mar 1995	A
5409019	Wilk	Apr 1995	A
5411552	Andersen et al.	May 1995	A
5425762	Muller	Jun 1995	A
5431676	Dubrul et al.	Jul 1995	A
5443446	Shturman	Aug 1995	A
5443449	Buelna	Aug 1995	A
5443477	Marin et al.	Aug 1995	A
5443495	Buscemi et al.	Aug 1995	A
5443499	Schmitt	Aug 1995	A
5476506	Lunn	Dec 1995	A
5476510	Eberhardt et al.	Dec 1995	A
5480423	Ravenscroft et al.	Jan 1996	A
5480424	Cox	Jan 1996	A
5500014	Quijano et al.	Mar 1996	A
5507767	Maeda et al.	Apr 1996	A
5534007	St. Germain et al.	Jul 1996	A
5545133	Burns et al.	Aug 1996	A
5545209	Roberts et al.	Aug 1996	A
5545211	An et al.	Aug 1996	A
5545214	Stevens	Aug 1996	A
5549665	Vesely et al.	Aug 1996	A
5554185	Block et al.	Sep 1996	A
5571175	Vanney et al.	Nov 1996	A
5571215	Sterman et al.	Nov 1996	A
5573520	Schwartz et al.	Nov 1996	A
5575818	Pinchuk	Nov 1996	A
5591185	Kilmer et al.	Jan 1997	A
5591195	Taheri et al.	Jan 1997	A
5607464	Trescony et al.	Mar 1997	A
5609626	Quijano et al.	Mar 1997	A
5645559	Hachtman et al.	Jul 1997	A
5662671	Barbut et al.	Sep 1997	A
5667523	Bynon et al.	Sep 1997	A
5674277	Freitag	Oct 1997	A
5693083	Baker et al.	Dec 1997	A
5693310	Gries et al.	Dec 1997	A
5695498	Tower	Dec 1997	A
5709713	Evans et al.	Jan 1998	A
5713951	Garrison et al.	Feb 1998	A
5713953	Vallana et al.	Feb 1998	A
5716370	Williamson, IV et al.	Feb 1998	A
5716417	Girard et al.	Feb 1998	A
5720391	Dohm et al.	Feb 1998	A
5725549	Lam	Mar 1998	A
5728068	Leone et al.	Mar 1998	A
5733325	Robinson et al.	Mar 1998	A
5735842	Krueger et al.	Apr 1998	A
5749890	Shaknovich	May 1998	A
5755783	Stobie et al.	May 1998	A
5756476	Epstein et al.	May 1998	A
5769812	Stevens et al.	Jun 1998	A
5772609	Nguyen et al.	Jun 1998	A
5800456	Maeda et al.	Sep 1998	A
5800531	Cosgrove et al.	Sep 1998	A
5807405	Vanney et al.	Sep 1998	A
5817126	Imran	Oct 1998	A
5824041	Lenker et al.	Oct 1998	A
5824043	Cottone, Jr.	Oct 1998	A
5824053	Khosravi et al.	Oct 1998	A
5824055	Spiridigliozzi et al.	Oct 1998	A
5824056	Rosenberg	Oct 1998	A
5824064	Taheri	Oct 1998	A
5840081	Andersen et al.	Nov 1998	A
5843158	Lenker et al.	Dec 1998	A
5855597	Jayaraman	Jan 1999	A
5855601	Bessler et al.	Jan 1999	A
5855602	Angell	Jan 1999	A
5860966	Tower	Jan 1999	A
5861024	Rashidi	Jan 1999	A
5861028	Angell	Jan 1999	A
5868783	Tower	Feb 1999	A
5876419	Carpenter et al.	Mar 1999	A
5876448	Thompson et al.	Mar 1999	A
5885228	Rosenman et al.	Mar 1999	A
5888201	Stinson et al.	Mar 1999	A
5891191	Stinson	Apr 1999	A
5895399	Barbut et al.	Apr 1999	A
5906619	Olson et al.	May 1999	A
5907893	Zadno-Azizi et al.	Jun 1999	A
5910154	Tsugita et al.	Jun 1999	A
5911734	Tsugita et al.	Jun 1999	A
5925063	Khosravi	Jul 1999	A
5944738	Amplatz et al.	Aug 1999	A
5954766	Zadno-Azizi et al.	Sep 1999	A
5957949	Leonhardt et al.	Sep 1999	A
5968070	Bley et al.	Oct 1999	A
5984957	Laptewicz, Jr. et al.	Nov 1999	A
5984959	Robertson et al.	Nov 1999	A
5993469	McKenzie et al.	Nov 1999	A
5997557	Barbut et al.	Dec 1999	A
6010522	Barbut et al.	Jan 2000	A
6022370	Tower	Feb 2000	A
6027520	Tsugita et al.	Feb 2000	A
6027525	Suh et al.	Feb 2000	A
6042598	Tsugita et al.	Mar 2000	A
6042607	Williamson, IV et al.	Mar 2000	A
6051014	Jang	Apr 2000	A
6059827	Fenton, Jr.	May 2000	A
6074418	Buchanan et al.	Jun 2000	A
6093203	Uflacker	Jul 2000	A
6096074	Pedros	Aug 2000	A
6123723	Konya et al.	Sep 2000	A
6132473	Williams et al.	Oct 2000	A
6139510	Palermo	Oct 2000	A
6142987	Tsugita	Nov 2000	A
6146366	Schachar	Nov 2000	A
6162245	Jayaraman	Dec 2000	A
6165200	Tsugita et al.	Dec 2000	A
6165209	Patterson et al.	Dec 2000	A
6168579	Tsugita	Jan 2001	B1
6168614	Andersen et al.	Jan 2001	B1
6171327	Daniel et al.	Jan 2001	B1
6171335	Wheatley et al.	Jan 2001	B1
6179859	Bates et al.	Jan 2001	B1
6187016	Hedges et al.	Feb 2001	B1
6197053	Cosgrove et al.	Mar 2001	B1
6200336	Pavcnik et al.	Mar 2001	B1
6214036	Letendre et al.	Apr 2001	B1
6221006	Dubrul et al.	Apr 2001	B1
6221091	Khosravi	Apr 2001	B1
6221096	Aiba et al.	Apr 2001	B1
6221100	Strecker	Apr 2001	B1
6231544	Tsugita et al.	May 2001	B1
6231551	Barbut	May 2001	B1
6241757	An et al.	Jun 2001	B1
6245102	Jayaraman	Jun 2001	B1
6251135	Stinson et al.	Jun 2001	B1
6258114	Konya et al.	Jul 2001	B1
6258115	Dubrul	Jul 2001	B1
6258120	McKenzie et al.	Jul 2001	B1
6258129	Dybdal et al.	Jul 2001	B1
6267783	Letendre et al.	Jul 2001	B1
6270513	Tsugita et al.	Aug 2001	B1
6277555	Duran et al.	Aug 2001	B1
6299637	Shaolian et al.	Oct 2001	B1
6302906	Goicoechea et al.	Oct 2001	B1
6309417	Spence et al.	Oct 2001	B1
6319281	Patel	Nov 2001	B1
6327772	Zadno-Azizi et al.	Dec 2001	B1
6336934	Gilson et al.	Jan 2002	B1
6336937	Vonesh et al.	Jan 2002	B1
6338735	Stevens	Jan 2002	B1
6346116	Brooks et al.	Feb 2002	B1
6348063	Yassour et al.	Feb 2002	B1
6352554	De Paulis	Mar 2002	B2
6352708	Duran et al.	Mar 2002	B1
6361545	Macoviak et al.	Mar 2002	B1
6363938	Saadat et al.	Apr 2002	B2
6364895	Greenhalgh	Apr 2002	B1
6371970	Khosravi et al.	Apr 2002	B1
6371983	Lane	Apr 2002	B1
6379383	Palmaz et al.	Apr 2002	B1
6398807	Chouinard et al.	Jun 2002	B1
6402736	Brown et al.	Jun 2002	B1
6409750	Hyodoh et al.	Jun 2002	B1
6416510	Altman et al.	Jul 2002	B1
6425916	Garrison et al.	Jul 2002	B1
6440164	DiMatteo et al.	Aug 2002	B1
6454799	Schreck	Sep 2002	B1
6458153	Bailey et al.	Oct 2002	B1
6461382	Cao	Oct 2002	B1
6468303	Amplatz et al.	Oct 2002	B1
6468660	Ogle et al.	Oct 2002	B2
6475239	Campbell et al.	Nov 2002	B1
6482228	Norred	Nov 2002	B1
6485501	Green	Nov 2002	B1
6485502	Don Michael et al.	Nov 2002	B2
6488704	Connelly et al.	Dec 2002	B1
6494909	Greenhalgh	Dec 2002	B2
6503272	Duerig et al.	Jan 2003	B2
6508803	Horikawa et al.	Jan 2003	B1
6508833	Pavcnik et al.	Jan 2003	B2
6527800	McGuckin, Jr. et al.	Mar 2003	B1
6530949	Konya et al.	Mar 2003	B2
6530952	Vesely	Mar 2003	B2
6537297	Tsugita et al.	Mar 2003	B2
6540768	Diaz et al.	Apr 2003	B1
6562058	Seguin et al.	May 2003	B2
6569196	Vesely	May 2003	B1
6572643	Gharibadeh	Jun 2003	B1
6585766	Huynh et al.	Jul 2003	B1
6592546	Barbut et al.	Jul 2003	B1
6592614	Lenker et al.	Jul 2003	B2
6605112	Moll et al.	Aug 2003	B1
6610077	Hancock et al.	Aug 2003	B1
6616682	Joergensen et al.	Sep 2003	B2
6622604	Chouinard et al.	Sep 2003	B1
6623518	Thompson et al.	Sep 2003	B2
6623521	Steinke et al.	Sep 2003	B2
6632243	Zadno-Azizi et al.	Oct 2003	B1
6635068	Dubrul et al.	Oct 2003	B1
6635079	Unsworth et al.	Oct 2003	B2
6652571	White et al.	Nov 2003	B1
6652578	Bailey et al.	Nov 2003	B2
6663588	DuBois et al.	Dec 2003	B2
6663663	Kim et al.	Dec 2003	B2
6669724	Park et al.	Dec 2003	B2
6673089	Yassour et al.	Jan 2004	B1
6673109	Cox	Jan 2004	B2
6676668	Mercereau et al.	Jan 2004	B2
6676692	Rabkin et al.	Jan 2004	B2
6676698	McGuckin, Jr. et al.	Jan 2004	B2
6682543	Barbut et al.	Jan 2004	B2
6682558	Tu et al.	Jan 2004	B2
6682559	Myers et al.	Jan 2004	B2
6685739	DiMatteo et al.	Feb 2004	B2
6689144	Gerberding	Feb 2004	B2
6689164	Seguin	Feb 2004	B1
6692512	Jang	Feb 2004	B2
6695864	Macoviak et al.	Feb 2004	B2
6695865	Boyle et al.	Feb 2004	B2
6702851	Chinn et al.	Mar 2004	B1
6712842	Gifford, III et al.	Mar 2004	B1
6712843	Elliott	Mar 2004	B2
6714842	Ito	Mar 2004	B1
6719789	Cox	Apr 2004	B2
6723116	Taheri	Apr 2004	B2
6730118	Spenser et al.	May 2004	B2
6730377	Wang	May 2004	B2
6733525	Yang et al.	May 2004	B2
6736846	Cox	May 2004	B2
6752828	Thornton	Jun 2004	B2
6755854	Gillick et al.	Jun 2004	B2
6758855	Fulton, III et al.	Jul 2004	B2
6764503	Ishimaru	Jul 2004	B1
6764509	Chinn et al.	Jul 2004	B2
6767345	St. Germain et al.	Jul 2004	B2
6769434	Liddicoat et al.	Aug 2004	B2
6773454	Wholey et al.	Aug 2004	B2
6776791	Stallings et al.	Aug 2004	B1
6786925	Schoon et al.	Sep 2004	B1
6790229	Berreklouw	Sep 2004	B1
6790230	Beyersdorf et al.	Sep 2004	B2
6790237	Stinson	Sep 2004	B2
6792979	Konya et al.	Sep 2004	B2
6797002	Spence et al.	Sep 2004	B2
6814746	Thompson et al.	Nov 2004	B2
6821297	Snyders	Nov 2004	B2
6830585	Artof et al.	Dec 2004	B1
6837901	Rabkin et al.	Jan 2005	B2
6840957	DiMatteo et al.	Jan 2005	B2
6843802	Villalobos et al.	Jan 2005	B1
6849085	Marton	Feb 2005	B2
6863668	Gillespie et al.	Mar 2005	B2
6866650	Stevens et al.	Mar 2005	B2
6866669	Buzzard et al.	Mar 2005	B2
6872223	Roberts et al.	Mar 2005	B2
6872226	Cali et al.	Mar 2005	B2
6875231	Anduiza et al.	Apr 2005	B2
6881220	Edwin et al.	Apr 2005	B2
6887266	Williams et al.	May 2005	B2
6890340	Duane	May 2005	B2
6893459	Macoviak	May 2005	B1
6893460	Spenser et al.	May 2005	B2
6905743	Chen et al.	Jun 2005	B1
6908481	Cribier	Jun 2005	B2
6911036	Douk et al.	Jun 2005	B2
6911043	Myers et al.	Jun 2005	B2
6936058	Forde et al.	Aug 2005	B2
6936067	Buchanan	Aug 2005	B2
6939352	Buzzard et al.	Sep 2005	B2
6951571	Srivastava	Oct 2005	B1
6953332	Kurk et al.	Oct 2005	B1
6964673	Tsugita et al.	Nov 2005	B2
6969395	Eskuri	Nov 2005	B2
6972025	WasDyke	Dec 2005	B2
6974464	Quijano et al.	Dec 2005	B2
6974474	Pavcnik et al.	Dec 2005	B2
6974476	McGuckin, Jr. et al.	Dec 2005	B2
6979350	Moll et al.	Dec 2005	B2
6984242	Campbell et al.	Jan 2006	B2
6989027	Allen et al.	Jan 2006	B2
7004176	Lau	Feb 2006	B2
7011681	Vesely	Mar 2006	B2
7018406	Seguin et al.	Mar 2006	B2
7025791	Levine et al.	Apr 2006	B2
7037331	Mitelberg et al.	May 2006	B2
7041132	Quijano et al.	May 2006	B2
7097658	Oktay	Aug 2006	B2
7122020	Mogul	Oct 2006	B2
7125418	Duran et al.	Oct 2006	B2
7141063	White et al.	Nov 2006	B2
7166097	Barbut	Jan 2007	B2
7175653	Gaber	Feb 2007	B2
7175654	Bonsignore et al.	Feb 2007	B2
7175656	Khairkhahan	Feb 2007	B2
7189258	Johnson et al.	Mar 2007	B2
7191018	Gielen et al.	Mar 2007	B2
7201772	Schwammenthal et al.	Apr 2007	B2
7235093	Gregorich	Jun 2007	B2
7258696	Rabkin et al.	Aug 2007	B2
7267686	DiMatteo et al.	Sep 2007	B2
7276078	Spenser et al.	Oct 2007	B2
7322932	Xie et al.	Jan 2008	B2
7326236	Andreas et al.	Feb 2008	B2
7329279	Haug et al.	Feb 2008	B2
7374560	Ressemann et al.	May 2008	B2
7381219	Salahieh et al.	Jun 2008	B2
7381220	Macoviak et al.	Jun 2008	B2
7399315	Iobbi	Jul 2008	B2
7445631	Salahieh et al.	Nov 2008	B2
7470285	Nugent et al.	Dec 2008	B2
7491232	Bolduc et al.	Feb 2009	B2
7510574	Lê et al.	Mar 2009	B2
7524330	Berreklouw	Apr 2009	B2
7530995	Quijano et al.	May 2009	B2
7544206	Cohn	Jun 2009	B2
7622276	Cunanan et al.	Nov 2009	B2
7628803	Pavcnik et al.	Dec 2009	B2
7632298	Hijlkema et al.	Dec 2009	B2
7674282	Wu et al.	Mar 2010	B2
7712606	Salahieh et al.	May 2010	B2
7722638	Deyette, Jr. et al.	May 2010	B2
7722662	Steinke et al.	May 2010	B2
7722666	Lafontaine	May 2010	B2
7736388	Goldfarb et al.	Jun 2010	B2
7748389	Salahieh et al.	Jul 2010	B2
7758625	Wu et al.	Jul 2010	B2
7780725	Haug et al.	Aug 2010	B2
7799065	Pappas	Sep 2010	B2
7803185	Gabbay	Sep 2010	B2
7824442	Salahieh et al.	Nov 2010	B2
7824443	Salahieh et al.	Nov 2010	B2
7833262	McGuckin, Jr. et al.	Nov 2010	B2
7846204	Letac et al.	Dec 2010	B2
7892292	Stack et al.	Feb 2011	B2
7918880	Austin	Apr 2011	B2
7938851	Olson et al.	May 2011	B2
7959666	Salahieh et al.	Jun 2011	B2
7959672	Salahieh et al.	Jun 2011	B2
7988724	Salahieh et al.	Aug 2011	B2
8048153	Salahieh et al.	Nov 2011	B2
8052749	Salahieh et al.	Nov 2011	B2
8136659	Salahieh et al.	Mar 2012	B2
8157853	Laske et al.	Apr 2012	B2
8182528	Salahieh et al.	May 2012	B2
8192351	Fishler et al.	Jun 2012	B2
8226710	Nguyen et al.	Jul 2012	B2
8231670	Salahieh et al.	Jul 2012	B2
8236049	Rowe et al.	Aug 2012	B2
8246678	Salahieh et al.	Aug 2012	B2
8252051	Chau et al.	Aug 2012	B2
8252052	Salahieh et al.	Aug 2012	B2
8287584	Salahieh et al.	Oct 2012	B2
8308798	Pintor et al.	Nov 2012	B2
8323335	Rowe et al.	Dec 2012	B2
8328868	Paul et al.	Dec 2012	B2
8343213	Salahieh et al.	Jan 2013	B2
8376865	Forster et al.	Feb 2013	B2
8377117	Keidar et al.	Feb 2013	B2
8398708	Meiri et al.	Mar 2013	B2
8403983	Quadri et al.	Mar 2013	B2
8579962	Salahieh et al.	Nov 2013	B2
8603160	Salahieh et al.	Dec 2013	B2
8617236	Paul et al.	Dec 2013	B2
8623074	Ryan	Jan 2014	B2
8623076	Salahieh et al.	Jan 2014	B2
8623078	Salahieh et al.	Jan 2014	B2
8668733	Haug et al.	Mar 2014	B2
8795354	Benichou et al.	Aug 2014	B2
8828078	Salahieh et al.	Sep 2014	B2
8840662	Salahieh et al.	Sep 2014	B2
8840663	Salahieh et al.	Sep 2014	B2
8858620	Salahieh et al.	Oct 2014	B2
8992608	Haug et al.	Mar 2015	B2
9283072	Bruchman et al.	Mar 2016	B2
9393114	Sutton	Jul 2016	B2
9901445	Backus	Feb 2018	B2
20010002445	Vesely	May 2001	A1
20010007956	Letac et al.	Jul 2001	A1
20010010017	Letac et al.	Jul 2001	A1
20010021872	Bailey et al.	Sep 2001	A1
20010025196	Chinn et al.	Sep 2001	A1
20010032013	Marton	Oct 2001	A1
20010039450	Pavcnik et al.	Nov 2001	A1
20010041928	Pavcnik et al.	Nov 2001	A1
20010041930	Globerman et al.	Nov 2001	A1
20010044634	Don Michael et al.	Nov 2001	A1
20010044652	Moore	Nov 2001	A1
20010044656	Williamson, IV et al.	Nov 2001	A1
20020002396	Fulkerson	Jan 2002	A1
20020010489	Grayzel et al.	Jan 2002	A1
20020026233	Shaknovich	Feb 2002	A1
20020029014	Jayaraman	Mar 2002	A1
20020029981	Nigam	Mar 2002	A1
20020032480	Spence et al.	Mar 2002	A1
20020032481	Gabbay	Mar 2002	A1
20020042651	Liddicoat et al.	Apr 2002	A1
20020052651	Myers et al.	May 2002	A1
20020055767	Forde et al.	May 2002	A1
20020055769	Wang	May 2002	A1
20020058995	Stevens	May 2002	A1
20020077696	Zadno-Azizi et al.	Jun 2002	A1
20020082609	Green	Jun 2002	A1
20020095173	Mazzocchi	Jul 2002	A1
20020095209	Zadno-Azizi et al.	Jul 2002	A1
20020111674	Chouinard et al.	Aug 2002	A1
20020120328	Pathak et al.	Aug 2002	A1
20020123802	Snyders	Sep 2002	A1
20020138138	Yang	Sep 2002	A1
20020151970	Garrison et al.	Oct 2002	A1
20020161390	Mouw	Oct 2002	A1
20020161392	Dubrul	Oct 2002	A1
20020161394	Macoviak et al.	Oct 2002	A1
20020165576	Boyle et al.	Nov 2002	A1
20020177766	Mogul	Nov 2002	A1
20020183781	Casey et al.	Dec 2002	A1
20020188341	Elliott	Dec 2002	A1
20020188344	Bolea et al.	Dec 2002	A1
20020193871	Beyersdorf et al.	Dec 2002	A1
20030014104	Cribier	Jan 2003	A1
20030023303	Palmaz et al.	Jan 2003	A1
20030028247	Cali	Feb 2003	A1
20030036791	Philipp et al.	Feb 2003	A1
20030040736	Stevens et al.	Feb 2003	A1
20030040771	Hyodoh et al.	Feb 2003	A1
20030040772	Hyodoh et al.	Feb 2003	A1
20030040791	Oktay	Feb 2003	A1
20030040792	Gabbay	Feb 2003	A1
20030050694	Yang et al.	Mar 2003	A1
20030055495	Pease et al.	Mar 2003	A1
20030057156	Peterson et al.	Mar 2003	A1
20030060844	Borillo et al.	Mar 2003	A1
20030069492	Abrams et al.	Apr 2003	A1
20030069646	Stinson	Apr 2003	A1
20030070944	Nigam	Apr 2003	A1
20030100918	Duane	May 2003	A1
20030100919	Hopkins et al.	May 2003	A1
20030109924	Cribier	Jun 2003	A1
20030109930	Bluni et al.	Jun 2003	A1
20030114912	Sequin et al.	Jun 2003	A1
20030114913	Spenser et al.	Jun 2003	A1
20030125795	Pavcnik et al.	Jul 2003	A1
20030130729	Paniagua et al.	Jul 2003	A1
20030135257	Taheri	Jul 2003	A1
20030144732	Cosgrove et al.	Jul 2003	A1
20030149475	Hyodoh et al.	Aug 2003	A1
20030149476	Damm et al.	Aug 2003	A1
20030149478	Figulla et al.	Aug 2003	A1
20030153974	Spenser et al.	Aug 2003	A1
20030171803	Shimon	Sep 2003	A1
20030176884	Berrada et al.	Sep 2003	A1
20030181850	Diamond et al.	Sep 2003	A1
20030187495	Cully et al.	Oct 2003	A1
20030191516	Weldon et al.	Oct 2003	A1
20030195609	Berenstein et al.	Oct 2003	A1
20030199759	Richard	Oct 2003	A1
20030199913	Dubrul et al.	Oct 2003	A1
20030199971	Tower et al.	Oct 2003	A1
20030199972	Zadno-Azizi et al.	Oct 2003	A1
20030208224	Broome	Nov 2003	A1
20030212429	Keegan et al.	Nov 2003	A1
20030212452	Zadno-Azizi et al.	Nov 2003	A1
20030212454	Scott et al.	Nov 2003	A1
20030216774	Larson	Nov 2003	A1
20030225445	Derus et al.	Dec 2003	A1
20030229390	Ashton et al.	Dec 2003	A1
20030233117	Adams et al.	Dec 2003	A1
20040019374	Hojeibane et al.	Jan 2004	A1
20040034411	Quijano et al.	Feb 2004	A1
20040039436	Spenser et al.	Feb 2004	A1
20040049224	Buehlmann et al.	Mar 2004	A1
20040049226	Keegan et al.	Mar 2004	A1
20040049262	Obermiller et al.	Mar 2004	A1
20040049266	Anduiza et al.	Mar 2004	A1
20040059409	Stenzel	Mar 2004	A1
20040073198	Gilson et al.	Apr 2004	A1
20040082904	Houde et al.	Apr 2004	A1
20040082967	Broome et al.	Apr 2004	A1
20040087982	Eskuri	May 2004	A1
20040088045	Cox	May 2004	A1
20040093016	Root et al.	May 2004	A1
20040093060	Seguin et al.	May 2004	A1
20040097788	Mourlas et al.	May 2004	A1
20040098022	Barone	May 2004	A1
20040098098	McGuckin, Jr. et al.	May 2004	A1
20040098099	McCullagh et al.	May 2004	A1
20040098112	DiMatteo et al.	May 2004	A1
20040107004	Levine et al.	Jun 2004	A1
20040111096	Tu et al.	Jun 2004	A1
20040116951	Rosengart	Jun 2004	A1
20040117004	Osborne et al.	Jun 2004	A1
20040117009	Cali et al.	Jun 2004	A1
20040122468	Yodfat et al.	Jun 2004	A1
20040122516	Fogarty et al.	Jun 2004	A1
20040127936	Salahieh et al.	Jul 2004	A1
20040127979	Wilson et al.	Jul 2004	A1
20040133274	Webler et al.	Jul 2004	A1
20040138694	Tran et al.	Jul 2004	A1
20040138742	Myers et al.	Jul 2004	A1
20040138743	Myers et al.	Jul 2004	A1
20040148018	Carpentier et al.	Jul 2004	A1
20040148021	Cartledge et al.	Jul 2004	A1
20040153094	Dunfee et al.	Aug 2004	A1
20040158277	Lowe et al.	Aug 2004	A1
20040167565	Beulke et al.	Aug 2004	A1
20040167620	Ortiz et al.	Aug 2004	A1
20040181140	Falwell et al.	Sep 2004	A1
20040186558	Pavcnik et al.	Sep 2004	A1
20040186563	Lobbi	Sep 2004	A1
20040193261	Berreklouw	Sep 2004	A1
20040199245	Lauterjung	Oct 2004	A1
20040204755	Robin	Oct 2004	A1
20040210304	Seguin et al.	Oct 2004	A1
20040210306	Quijano et al.	Oct 2004	A1
20040210307	Khairkhahan	Oct 2004	A1
20040215331	Chew et al.	Oct 2004	A1
20040215333	Duran et al.	Oct 2004	A1
20040215339	Drasler et al.	Oct 2004	A1
20040220655	Swanson et al.	Nov 2004	A1
20040225321	Krolik et al.	Nov 2004	A1
20040225353	McGuckin, Jr. et al.	Nov 2004	A1
20040225354	Allen et al.	Nov 2004	A1
20040225355	Stevens	Nov 2004	A1
20040243221	Fawzi et al.	Dec 2004	A1
20040254636	Flagle et al.	Dec 2004	A1
20040260390	Sarac et al.	Dec 2004	A1
20050010287	Macoviak et al.	Jan 2005	A1
20050021136	Xie et al.	Jan 2005	A1
20050033398	Seguin	Feb 2005	A1
20050033402	Cully et al.	Feb 2005	A1
20050043711	Corcoran et al.	Feb 2005	A1
20050043757	Arad et al.	Feb 2005	A1
20050043790	Seguin	Feb 2005	A1
20050049692	Numamoto et al.	Mar 2005	A1
20050049696	Siess et al.	Mar 2005	A1
20050055088	Liddicoat et al.	Mar 2005	A1
20050060016	Wu et al.	Mar 2005	A1
20050060029	Le et al.	Mar 2005	A1
20050065594	DiMatteo et al.	Mar 2005	A1
20050075584	Cali	Apr 2005	A1
20050075662	Pedersen et al.	Apr 2005	A1
20050075712	Biancucci et al.	Apr 2005	A1
20050075717	Nguyen et al.	Apr 2005	A1
20050075719	Bergheim	Apr 2005	A1
20050075724	Svanidze et al.	Apr 2005	A1
20050075730	Myers et al.	Apr 2005	A1
20050075731	Artof et al.	Apr 2005	A1
20050085841	Eversull et al.	Apr 2005	A1
20050085842	Eversull et al.	Apr 2005	A1
20050085843	Opolski et al.	Apr 2005	A1
20050085890	Rasmussen et al.	Apr 2005	A1
20050090846	Pedersen et al.	Apr 2005	A1
20050090890	Wu et al.	Apr 2005	A1
20050096692	Linder et al.	May 2005	A1
20050096734	Majercak et al.	May 2005	A1
20050096735	Hojeibane et al.	May 2005	A1
20050096736	Osse et al.	May 2005	A1
20050096738	Cali et al.	May 2005	A1
20050100580	Osborne et al.	May 2005	A1
20050107822	Wasdyke	May 2005	A1
20050113910	Paniagua et al.	May 2005	A1
20050131438	Cohn	Jun 2005	A1
20050137683	Hezi-Yamit et al.	Jun 2005	A1
20050137686	Salahieh et al.	Jun 2005	A1
20050137687	Salahieh et al.	Jun 2005	A1
20050137688	Salahieh et al.	Jun 2005	A1
20050137689	Salahieh et al.	Jun 2005	A1
20050137690	Salahieh et al.	Jun 2005	A1
20050137691	Salahieh et al.	Jun 2005	A1
20050137692	Haug et al.	Jun 2005	A1
20050137693	Haug et al.	Jun 2005	A1
20050137694	Haug et al.	Jun 2005	A1
20050137695	Salahieh et al.	Jun 2005	A1
20050137696	Salahieh et al.	Jun 2005	A1
20050137697	Salahieh et al.	Jun 2005	A1
20050137698	Salahieh et al.	Jun 2005	A1
20050137699	Salahieh et al.	Jun 2005	A1
20050137701	Salahieh et al.	Jun 2005	A1
20050137702	Haug et al.	Jun 2005	A1
20050143807	Pavcnik et al.	Jun 2005	A1
20050143809	Salahieh et al.	Jun 2005	A1
20050149159	Andreas et al.	Jul 2005	A1
20050165352	Henry et al.	Jul 2005	A1
20050165477	Anduiza et al.	Jul 2005	A1
20050165479	Drews et al.	Jul 2005	A1
20050182486	Gabbay	Aug 2005	A1
20050197694	Pai et al.	Sep 2005	A1
20050197695	Stacchino et al.	Sep 2005	A1
20050203549	Realyvasquez	Sep 2005	A1
20050203614	Forster et al.	Sep 2005	A1
20050203615	Forster et al.	Sep 2005	A1
20050203616	Cribier	Sep 2005	A1
20050203617	Forster et al.	Sep 2005	A1
20050203618	Sharkawy et al.	Sep 2005	A1
20050209580	Freyman	Sep 2005	A1
20050228472	Case et al.	Oct 2005	A1
20050228495	Macoviak	Oct 2005	A1
20050234546	Nugent et al.	Oct 2005	A1
20050240200	Bergheim	Oct 2005	A1
20050240262	White	Oct 2005	A1
20050251250	Verhoeven et al.	Nov 2005	A1
20050251251	Cribier	Nov 2005	A1
20050261759	Lambrecht et al.	Nov 2005	A1
20050267560	Bates	Dec 2005	A1
20050283231	Haug et al.	Dec 2005	A1
20050283962	Boudjemline	Dec 2005	A1
20060004439	Spenser et al.	Jan 2006	A1
20060004442	Spenser et al.	Jan 2006	A1
20060015168	Gunderson	Jan 2006	A1
20060058872	Salahieh et al.	Mar 2006	A1
20060149360	Schwammenthal et al.	Jul 2006	A1
20060155312	Levine et al.	Jul 2006	A1
20060161249	Realyvasquez et al.	Jul 2006	A1
20060173524	Salahieh et al.	Aug 2006	A1
20060195183	Navia et al.	Aug 2006	A1
20060253191	Salahieh et al.	Nov 2006	A1
20060259134	Schwammenthal et al.	Nov 2006	A1
20060271166	Thill et al.	Nov 2006	A1
20060287668	Fawzi et al.	Dec 2006	A1
20060287717	Rowe et al.	Dec 2006	A1
20070010876	Salahieh et al.	Jan 2007	A1
20070010877	Salahieh et al.	Jan 2007	A1
20070016286	Herrmann et al.	Jan 2007	A1
20070055340	Pryor	Mar 2007	A1
20070061008	Salahieh et al.	Mar 2007	A1
20070112355	Salahieh et al.	May 2007	A1
20070118214	Salahieh et al.	May 2007	A1
20070162107	Haug et al.	Jul 2007	A1
20070173918	Dreher et al.	Jul 2007	A1
20070203503	Salahieh et al.	Aug 2007	A1
20070244552	Salahieh et al.	Oct 2007	A1
20070288089	Gurskis et al.	Dec 2007	A1
20080009940	Cribier	Jan 2008	A1
20080033541	Gelbart et al.	Feb 2008	A1
20080082165	Wilson et al.	Apr 2008	A1
20080125859	Salahieh et al.	May 2008	A1
20080188928	Salahieh et al.	Aug 2008	A1
20080208328	Antocci et al.	Aug 2008	A1
20080208332	Lamphere et al.	Aug 2008	A1
20080221672	Lamphere et al.	Sep 2008	A1
20080234814	Salahieh et al.	Sep 2008	A1
20080255661	Straubinger et al.	Oct 2008	A1
20080269878	Iobbi	Oct 2008	A1
20080288054	Pulnev et al.	Nov 2008	A1
20090005863	Goetz et al.	Jan 2009	A1
20090030512	Thielen et al.	Jan 2009	A1
20090054969	Salahieh et al.	Feb 2009	A1
20090076598	Salahieh et al.	Mar 2009	A1
20090093877	Keidar et al.	Apr 2009	A1
20090096598	Tengler et al.	Apr 2009	A1
20090171456	Kveen et al.	Jul 2009	A1
20090222076	Figulla et al.	Sep 2009	A1
20090264759	Byrd	Oct 2009	A1
20090264997	Salahieh et al.	Oct 2009	A1
20090299462	Fawzi et al.	Dec 2009	A1
20100049313	Alon et al.	Feb 2010	A1
20100094399	Dorn et al.	Apr 2010	A1
20100121434	Paul et al.	May 2010	A1
20100191326	Alkhatib	Jul 2010	A1
20100219092	Salahieh et al.	Sep 2010	A1
20100280495	Paul et al.	Nov 2010	A1
20110218619	Benichou et al.	Sep 2011	A1
20110257735	Salahieh et al.	Oct 2011	A1
20110276129	Salahieh et al.	Nov 2011	A1
20120016469	Salahieh et al.	Jan 2012	A1
20120016471	Salahieh et al.	Jan 2012	A1
20120022642	Haug et al.	Jan 2012	A1
20120029627	Salahieh et al.	Feb 2012	A1
20120041549	Salahieh et al.	Feb 2012	A1
20120041550	Salahieh et al.	Feb 2012	A1
20120046740	Paul et al.	Feb 2012	A1
20120053683	Salahieh et al.	Mar 2012	A1
20120089224	Haug et al.	Apr 2012	A1
20120132547	Salahieh et al.	May 2012	A1
20120197379	Laske et al.	Aug 2012	A1
20120330409	Haug et al.	Dec 2012	A1
20130013057	Salahieh et al.	Jan 2013	A1
20130018457	Gregg et al.	Jan 2013	A1
20130030520	Lee et al.	Jan 2013	A1
20130123796	Sutton et al.	May 2013	A1
20130158656	Sutton et al.	Jun 2013	A1
20130190865	Anderson	Jul 2013	A1
20130204360	Gainor	Aug 2013	A1
20130304199	Sutton et al.	Nov 2013	A1
20130310917	Richter et al.	Nov 2013	A1
20140018911	Zhou et al.	Jan 2014	A1
20140031924	Bruchman et al.	Jan 2014	A1
20140094904	Salahieh et al.	Apr 2014	A1
20140114340	Zhou	Apr 2014	A1
20140114405	Paul et al.	Apr 2014	A1
20140114406	Salahieh et al.	Apr 2014	A1
20140121766	Salahieh et al.	May 2014	A1
20140135912	Salahieh et al.	May 2014	A1
20140243967	Salahieh et al.	Aug 2014	A1
20140324160	Benichou et al.	Oct 2014	A1
20150245909	Salahieh et al.	Sep 2015	A1
20160143731	Backus	May 2016	A1
20160157998	Bruchman et al.	Jun 2016	A1
20160213467	Backus	Jul 2016	A1
20160220359	Backus	Aug 2016	A1
20160220360	Lin	Aug 2016	A1
20160256271	Backus	Sep 2016	A1
20160296322	Edelman	Oct 2016	A1
20170042669	Backus	Feb 2017	A1
20170042671	Backus	Feb 2017	A1
20170042672	Backus	Feb 2017	A1
20170042676	Backus	Feb 2017	A1
20170071729	Wrobel	Mar 2017	A1
20170304049	Hayes	Oct 2017	A1
20170319335	Backus	Nov 2017	A1
20170325928	Ino	Nov 2017	A1

Foreign Referenced Citations (145)

Number	Date	Country
1338951	Mar 2002	CN
19532846	Mar 1997	DE
19546692	Jun 1997	DE
19857887	Jul 2000	DE
19907646	Aug 2000	DE
10049812	Apr 2002	DE
10049813	Apr 2002	DE
10049814	Apr 2002	DE
10049815	Apr 2002	DE
0103546	May 1988	EP
0144167	Nov 1989	EP
0409929	Apr 1997	EP
0850607	Jul 1998	EP
0597967	Dec 1999	EP
1000590	May 2000	EP
1057459	Dec 2000	EP
1057460	Dec 2000	EP
1088529	Apr 2001	EP
0937439	Sep 2003	EP
1340473	Sep 2003	EP
1356793	Oct 2003	EP
1042045	May 2004	EP
0819013	Jun 2004	EP
1430853	Jun 2004	EP
1472996	Nov 2004	EP
1229864	Apr 2005	EP
1059894	Jul 2005	EP
1078610	Aug 2005	EP
1570809	Sep 2005	EP
1576937	Sep 2005	EP
1582178	Oct 2005	EP
1582179	Oct 2005	EP
1469797	Nov 2005	EP
1600121	Nov 2005	EP
1156757	Dec 2005	EP
1616531	Jan 2006	EP
1605871	Jul 2008	EP
2788217	Jul 2000	FR
2056023	Mar 1981	GB
2398245	Aug 2004	GB
1271508	Nov 1986	SU
1371700	Feb 1988	SU
9117720	Nov 1991	WO
9217118	Oct 1992	WO
9301768	Feb 1993	WO
9315693	Aug 1993	WO
9504556	Feb 1995	WO
9529640	Nov 1995	WO
9614032	May 1996	WO
9624306	Aug 1996	WO
9640012	Dec 1996	WO
9829057	Jul 1998	WO
9836790	Aug 1998	WO
9850103	Nov 1998	WO
9857599	Dec 1998	WO
9933414	Jul 1999	WO
9940964	Aug 1999	WO
9944542	Sep 1999	WO
9947075	Sep 1999	WO
0009059	Feb 2000	WO
0041652	Jul 2000	WO
0044308	Aug 2000	WO
0044311	Aug 2000	WO
0044313	Aug 2000	WO
0045874	Aug 2000	WO
0047139	Aug 2000	WO
0049970	Aug 2000	WO
0067661	Nov 2000	WO
0105331	Jan 2001	WO
0108596	Feb 2001	WO
0110320	Feb 2001	WO
0110343	Feb 2001	WO
0135870	May 2001	WO
0149213	Jul 2001	WO
0154625	Aug 2001	WO
0162189	Aug 2001	WO
0164137	Sep 2001	WO
0176510	Oct 2001	WO
0197715	Dec 2001	WO
0236048	May 2002	WO
0241789	May 2002	WO
0243620	Jun 2002	WO
0247575	Jun 2002	WO
02056955	Jul 2002	WO
02100297	Dec 2002	WO
03003943	Jan 2003	WO
03003949	Jan 2003	WO
03011195	Feb 2003	WO
03028592	Apr 2003	WO
03030776	Apr 2003	WO
03037227	May 2003	WO
03047648	Jun 2003	WO
03015851	Nov 2003	WO
03094793	Nov 2003	WO
03094797	Nov 2003	WO
2004006803	Jan 2004	WO
2004006804	Jan 2004	WO
2004014256	Feb 2004	WO
2004019811	Mar 2004	WO
2004019817	Mar 2004	WO
2004021922	Mar 2004	WO
2004023980	Mar 2004	WO
2004026117	Apr 2004	WO
2004041126	May 2004	WO
2004043293	May 2004	WO
2004047681	Jun 2004	WO
2004058106	Jul 2004	WO
2004066876	Aug 2004	WO
2004082536	Sep 2004	WO
2004089250	Oct 2004	WO
2004089253	Oct 2004	WO
2004093728	Nov 2004	WO
2004105651	Dec 2004	WO
2005002466	Jan 2005	WO
2005004753	Jan 2005	WO
2005009285	Feb 2005	WO
2005011534	Feb 2005	WO
2005011535	Feb 2005	WO
2005023155	Mar 2005	WO
2005027790	Mar 2005	WO
2005046528	May 2005	WO
2005046529	May 2005	WO
2005048883	Jun 2005	WO
2005062980	Jul 2005	WO
2005065585	Jul 2005	WO
2005084595	Sep 2005	WO
2005087140	Sep 2005	WO
2005096993	Oct 2005	WO
2006005015	Jan 2006	WO
2006009690	Jan 2006	WO
2006027499	Mar 2006	WO
2006138391	Dec 2006	WO
2007033093	Mar 2007	WO
2007035471	Mar 2007	WO
2007044285	Apr 2007	WO
2007053243	Apr 2007	WO
2007058847	May 2007	WO
2007092354	Aug 2007	WO
2007097983	Aug 2007	WO
2010042950	Apr 2010	WO
2012116368	Aug 2012	WO
2013009975	Jan 2013	WO
2013028387	Feb 2013	WO
2013096545	Jun 2013	WO
2016126511	Aug 2016	WO

Non-Patent Literature Citations (1)

Entry
International Search Report and Written Opinion dated Jul. 28, 2017 for International Application No. PCT/US2017/032284.

Related Publications (1)

	Number	Date	Country
	20170325938 A1	Nov 2017	US

Provisional Applications (1)

	Number	Date	Country
	62336944	May 2016	US

Replacement heart valve implant with invertible leaflets

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Abstract